Query         026073
Match_columns 244
No_of_seqs    118 out of 141
Neff          6.0 
Searched_HMMs 46136
Date          Fri Mar 29 03:25:38 2013
Command       hhsearch -i /work/01045/syshi/csienesis_hhblits_a3m/026073.a3m -d /work/01045/syshi/HHdatabase/Cdd.hhm -o /work/01045/syshi/hhsearch_cdd/026073hhsearch_cdd -cpu 12 -v 0 

 No Hit                             Prob E-value P-value  Score    SS Cols Query HMM  Template HMM
  1 PF08767 CRM1_C:  CRM1 C termin  83.7      37  0.0008   31.5  13.8   92  107-198   202-315 (319)
  2 PF11865 DUF3385:  Domain of un  77.3      18  0.0004   30.1   8.4   45  108-152    78-122 (160)
  3 PF13660 DUF4147:  Domain of un  73.8     3.2 6.9E-05   37.3   3.1   67  158-224   129-199 (238)
  4 cd05167 PI4Kc_III_alpha Phosph  68.0      26 0.00056   32.7   7.8   69  133-201   222-295 (311)
  5 PTZ00444 hypothetical protein;  62.6      20 0.00044   31.0   5.5   76  112-187    13-88  (184)
  6 COG2379 GckA Putative glycerat  61.2      19 0.00042   34.8   5.6   77  158-235   125-205 (422)
  7 KOG2022 Nuclear transport rece  60.9      98  0.0021   33.1  11.0   84  113-200   884-977 (982)
  8 PF04675 DNA_ligase_A_N:  DNA l  54.7      29 0.00064   28.7   5.2   67  134-207    87-156 (177)
  9 PF12717 Cnd1:  non-SMC mitotic  53.8 1.3E+02  0.0028   25.0  10.7  132   54-199     9-157 (178)
 10 cd00893 PI4Kc_III Phosphoinosi  50.6      61  0.0013   29.9   7.0   86  111-200   182-272 (289)
 11 cd05174 PI3Kc_IA_delta Phospho  50.2      46 0.00099   31.8   6.3   69  133-201   273-347 (361)
 12 cd05168 PI4Kc_III_beta Phospho  47.5      65  0.0014   29.8   6.7   69  132-200   200-276 (293)
 13 PF05004 IFRD:  Interferon-rela  46.8 2.4E+02  0.0051   26.0  11.2   95   92-196   206-307 (309)
 14 PRK14707 hypothetical protein;  44.2 1.5E+02  0.0032   35.0   9.7  124   55-195   438-568 (2710)
 15 cd00891 PI3Kc Phosphoinositide  42.4      94   0.002   29.4   7.1   88  111-202   247-340 (352)
 16 cd05166 PI3Kc_II Phosphoinosit  41.6 1.1E+02  0.0025   28.9   7.5   70  132-201   265-340 (353)
 17 cd00895 PI3Kc_C2_beta Phosphoi  41.6      75  0.0016   30.3   6.2   71  132-202   266-342 (354)
 18 cd05176 PI3Kc_C2_alpha Phospho  41.4      93   0.002   29.6   6.8   71  133-203   266-342 (353)
 19 cd05165 PI3Kc_I Phosphoinositi  41.4      83  0.0018   30.1   6.6   71  131-201   276-352 (366)
 20 cd00896 PI3Kc_III Phosphoinosi  40.5 1.1E+02  0.0023   29.1   7.1   73  133-205   259-339 (350)
 21 PRK10702 endonuclease III; Pro  39.7   1E+02  0.0022   26.9   6.5   57  114-172    68-124 (211)
 22 cd05177 PI3Kc_C2_gamma Phospho  37.7      84  0.0018   29.9   5.9   67  133-199   267-339 (354)
 23 PF12783 Sec7_N:  Guanine nucle  37.2 1.4E+02   0.003   24.5   6.6   78  107-199    64-146 (168)
 24 KOG2020 Nuclear transport rece  36.6      91   0.002   33.9   6.6   25    2-26    829-853 (1041)
 25 cd00894 PI3Kc_IB_gamma Phospho  36.0      95  0.0021   29.7   6.0   69  132-200   276-350 (365)
 26 PF02637 GatB_Yqey:  GatB domai  33.8 2.5E+02  0.0055   22.6   8.1   51  164-216    39-90  (148)
 27 PRK09614 nrdF ribonucleotide-d  33.4 1.5E+02  0.0033   27.2   6.9   70  105-179   196-265 (324)
 28 cd05173 PI3Kc_IA_beta Phosphoi  32.4      84  0.0018   30.0   5.0   70  132-201   272-347 (362)
 29 PRK09169 hypothetical protein;  29.1 3.1E+02  0.0067   32.6   9.3  123   55-193   228-356 (2316)
 30 cd00056 ENDO3c endonuclease II  28.7 2.8E+02  0.0061   22.2   7.0   61  116-179    42-105 (158)
 31 PF13495 Phage_int_SAM_4:  Phag  27.2      47   0.001   23.6   1.9   61  133-202    18-83  (85)
 32 COG0208 NrdF Ribonucleotide re  26.9 2.2E+02  0.0048   27.0   6.8   72  105-179   219-290 (348)
 33 cd05175 PI3Kc_IA_alpha Phospho  26.7 1.6E+02  0.0034   28.3   5.8   71  131-201   276-352 (366)
 34 PRK07209 ribonucleotide-diphos  26.0 2.1E+02  0.0045   27.1   6.5   72  105-179   246-318 (369)
 35 PF04255 DUF433:  Protein of un  25.5 1.5E+02  0.0032   20.2   4.1   31  143-174    23-53  (56)
 36 TIGR01083 nth endonuclease III  24.7 3.6E+02  0.0078   22.8   7.2   61  115-177    66-126 (191)
 37 PF06479 Ribonuc_2-5A:  Ribonuc  23.9      60  0.0013   26.4   2.1   37  127-163    56-92  (129)
 38 PF05918 API5:  Apoptosis inhib  22.3      63  0.0014   32.7   2.3   21    4-24    185-205 (556)
 39 PF01736 Polyoma_agno:  Polyoma  22.3      85  0.0018   22.1   2.3   16   58-77     27-42  (62)
 40 KOG2122 Beta-catenin-binding p  21.8 1.2E+03   0.025   27.4  11.5  118   76-200   375-508 (2195)
 41 PRK12759 bifunctional gluaredo  21.0 2.8E+02   0.006   26.6   6.4   72  105-179   280-353 (410)
 42 KOG2583 Ubiquinol cytochrome c  20.7 1.9E+02  0.0041   28.3   5.1   26  154-179   384-409 (429)
 43 PRK14707 hypothetical protein;  20.7 5.6E+02   0.012   30.7   9.2  124   72-212   291-419 (2710)
 44 COG0177 Nth Predicted EndoIII-  20.7 1.7E+02  0.0036   25.9   4.4   53  114-168    68-120 (211)
 45 PF00633 HHH:  Helix-hairpin-he  20.3 1.4E+02   0.003   18.0   2.7   21  153-173     7-27  (30)

No 1  
>PF08767 CRM1_C:  CRM1 C terminal;  InterPro: IPR014877 CRM1 (also known as Exportin1) mediates the nuclear export of proteins bearing a leucine-rich nuclear export signal (NES). CRM1 forms a complex with the NES containing protein and the small GTPase Ran. This region forms an alpha helical structure formed by six helical hairpin motifs that are structurally similar to the HEAT repeat, but share little sequence similarity to the HEAT repeat []. ; PDB: 3M1I_C 3GB8_A 1W9C_A 3NC1_A 3NBY_D 3NBZ_D 3NC0_A 3GJX_D.
Probab=83.66  E-value=37  Score=31.45  Aligned_cols=92  Identities=17%  Similarity=0.215  Sum_probs=54.4

Q ss_pred             hhHHHHHHH---HHHHHHHHHhcccchHhhHHHHHHHHHHHHHH------hcCCCc-----------cHHHHHHh-CCCC
Q 026073          107 IELQQFVSK---DLFSAIIRGLALESNAVISADLVGLCREIFIY------MCDRDP-----------APRQVLLS-LPCI  165 (244)
Q Consensus       107 ~~l~efi~~---ev~~a~L~~L~~~~f~d~q~eL~~L~~~Iy~~------l~p~~~-----------~pr~vL~s-LP~I  165 (244)
                      +...+|...   ++++-++..|+|+......+.-..+++.++..      =.|..+           ...+.|.+ -|++
T Consensus       202 ~~~~~F~~~y~~~il~~if~vltD~~Hk~gf~~q~~iL~~Lf~~ve~~~i~~~l~~~~~~n~~~v~~~i~~~L~~~Fp~l  281 (319)
T PF08767_consen  202 EFANQFYQQYYLDILQDIFSVLTDSDHKSGFKLQSQILSNLFRLVESGSIQVPLFDPGMSNQEFVSEYIANLLSEAFPNL  281 (319)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHSTT-GGGHHHHHHHHHHHHHHHHTT-SSSSSSSTTT-HHHHHHHHHHHHHHHH-TTS
T ss_pred             HHHHHHHHHHHHHHHHHHHHHHHCcccHHHHHHHHHHHHHHHHHHHcccccccccCCCCccHHHHHHHHHHHHHHhCCCC
Confidence            334445443   34555556666665555444444444444422      112222           23345554 4999


Q ss_pred             CHHhHHHHHHHHhcCCC-hHHHHHHHHHHHhccC
Q 026073          166 TPQDLLAFEDALTKTAS-PREQKQHMRSLLVSGT  198 (244)
Q Consensus       166 ~~~~l~~f~~~L~~~~s-~K~QR~l~~~LL~~~~  198 (244)
                      +++.+..|-..|-+... ...=|.+++|||-.++
T Consensus       282 ~~~qi~~fv~~Lf~~~~d~~~Fk~~lrDFlI~~k  315 (319)
T PF08767_consen  282 SPKQIENFVQGLFELNNDPEKFKTHLRDFLIQLK  315 (319)
T ss_dssp             -HHHHHHHHHHHHHTTT-HHHHHHHHHHHHHHHT
T ss_pred             CHHHHHHHHHHHHHhcCCHHHHHHHHHHHhhhhh
Confidence            99999999999977555 7777999999998765


No 2  
>PF11865 DUF3385:  Domain of unknown function (DUF3385);  InterPro: IPR024585 This uncharacterised domain is is typically between 160 to 172 amino acids in length. It is found in the phosphatidylinositol kinase-related protein kinases TOR (target of rapamycin). In Saccharomyces cerevisiae the TOR proteins, TOR1 and TOR2, regulate growth in a rapamycin-sensitive manner [].
Probab=77.32  E-value=18  Score=30.13  Aligned_cols=45  Identities=16%  Similarity=0.088  Sum_probs=41.7

Q ss_pred             hHHHHHHHHHHHHHHHHhcccchHhhHHHHHHHHHHHHHHhcCCC
Q 026073          108 ELQQFVSKDLFSAIIRGLALESNAVISADLVGLCREIFIYMCDRD  152 (244)
Q Consensus       108 ~l~efi~~ev~~a~L~~L~~~~f~d~q~eL~~L~~~Iy~~l~p~~  152 (244)
                      ..+||..+-++.++++.|.|++...+|...++.+..||..++.++
T Consensus        78 ~~ee~y~~vvi~~L~~iL~D~sLs~~h~~vv~ai~~If~~l~~~c  122 (160)
T PF11865_consen   78 SSEEYYPTVVINALMRILRDPSLSSHHTAVVQAIMYIFKSLGLKC  122 (160)
T ss_pred             chHHHHHHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHHHhcCcCc
Confidence            578999999999999999999999999999999999998888774


No 3  
>PF13660 DUF4147:  Domain of unknown function (DUF4147); PDB: 1X3L_A 2B8N_A.
Probab=73.79  E-value=3.2  Score=37.29  Aligned_cols=67  Identities=22%  Similarity=0.314  Sum_probs=47.2

Q ss_pred             HHHhCC--CCCHHhHHHHHHHHhcCCChHHHHHHHHHHHhccCCCchHHHh-hhcccc-cccccCCCCCCC
Q 026073          158 VLLSLP--CITPQDLLAFEDALTKTASPREQKQHMRSLLVSGTGNNLKALA-AQKSVN-VITNVSTRPRSS  224 (244)
Q Consensus       158 vL~sLP--~I~~~~l~~f~~~L~~~~s~K~QR~l~~~LL~~~~g~~l~a~~-~~k~~~-~i~~v~~~~~~~  224 (244)
                      =|+.+|  ||+-+|+.++.+.|.+.+.+-++=+.+++-|..+||-.|-..+ ..+-.+ ++.||---+...
T Consensus       129 ALl~~P~~gisLed~~~~~~~Ll~sGa~I~EiN~VRkhLS~vKGG~La~~~~~a~v~sLilSDV~Gd~l~~  199 (238)
T PF13660_consen  129 ALLELPADGISLEDKQELTKLLLRSGADIHEINTVRKHLSRVKGGRLARAAAPARVVSLILSDVPGDDLSV  199 (238)
T ss_dssp             HHS--B-TT--HHHHHHHHHHHHHCT--HHHHHHHHHTTBSSTTTHHHHCHTTSEEEEEEE--STT--TTT
T ss_pred             HhhcCCCCCCCHHHHHHHHHHHHHCCCCHHHHHHHHHHHhcCCchHHHHHhcCCeEEEEEecCCCCCChhh
Confidence            455656  8999999999999999999999999999999999999988776 333333 788888776665


No 4  
>cd05167 PI4Kc_III_alpha Phosphoinositide 4-kinase (PI4K), Type III, alpha isoform, catalytic domain; The PI4K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases. PI4Ks catalyze the transfer of the gamma-phosphoryl group from ATP to the 4-hydroxyl of the inositol ring of D-myo-phosphatidylinositol (PtdIns) to generate PtdIns(4)P, the major precursor in the synthesis of other phosphoinositides including PtdIns(4,5)P2, PtdIns(3,4)P2, and PtdIns(3,4,5)P3. Two isoforms of type III PI4K, alpha and beta, exist in most eukaryotes. PI4KIIIalpha is a 220 kDa protein found in the plasma membrane and the endoplasmic reticulum (ER). The role of PI4KIIIalpha in the ER remains unclear. In the plasma membrane, it provides PtdIns(4)P, which is then converted by PI5Ks to PtdIns(4,5)P2, an important signaling mole
Probab=68.05  E-value=26  Score=32.70  Aligned_cols=69  Identities=19%  Similarity=0.243  Sum_probs=58.0

Q ss_pred             hHHHHHHHHHHHHHHhcCCCccHHHHHH-----hCCCCCHHhHHHHHHHHhcCCChHHHHHHHHHHHhccCCCc
Q 026073          133 ISADLVGLCREIFIYMCDRDPAPRQVLL-----SLPCITPQDLLAFEDALTKTASPREQKQHMRSLLVSGTGNN  201 (244)
Q Consensus       133 ~q~eL~~L~~~Iy~~l~p~~~~pr~vL~-----sLP~I~~~~l~~f~~~L~~~~s~K~QR~l~~~LL~~~~g~~  201 (244)
                      .......+|...|..+|......-.++.     .+|+++.+++..+.+.+.-..++++....|.+++....+.-
T Consensus       222 ~f~~F~~~~~~~~~~lR~~~~~il~l~~lm~~s~lp~~~~~~i~~l~~rf~l~~se~~a~~~~~~lI~~s~~~~  295 (311)
T cd05167         222 PFKWFVELCVRAFLAVRPYMDEIVSLVELMLDSGLPCFRGDTIKNLRQRFAPEKSEREAAEFMLSLIAESYEKF  295 (311)
T ss_pred             hHHHHHHHHHHHHHHHHcCHHHHHHHHHHHHcCCchhhhHHHHHHHHHHhCCCCCHHHHHHHHHHHHHHHHhch
Confidence            4567888999999999987776555443     58999999999999999888999999999999999887653


No 5  
>PTZ00444 hypothetical protein; Provisional
Probab=62.65  E-value=20  Score=31.02  Aligned_cols=76  Identities=17%  Similarity=0.150  Sum_probs=57.4

Q ss_pred             HHHHHHHHHHHHHhcccchHhhHHHHHHHHHHHHHHhcCCCccHHHHHHhCCCCCHHhHHHHHHHHhcCCChHHHH
Q 026073          112 FVSKDLFSAIIRGLALESNAVISADLVGLCREIFIYMCDRDPAPRQVLLSLPCITPQDLLAFEDALTKTASPREQK  187 (244)
Q Consensus       112 fi~~ev~~a~L~~L~~~~f~d~q~eL~~L~~~Iy~~l~p~~~~pr~vL~sLP~I~~~~l~~f~~~L~~~~s~K~QR  187 (244)
                      +++.+=|.+|+.-++--...++|.+++.=++.=+-.=...-|+|+||-..+-.|..+++++++..+.+..+...++
T Consensus        13 ~~~~~~~~a~l~p~~~k~~~~~q~~iikDia~e~k~~~e~lPt~~~v~~~~~~id~e~~~kl~~~i~~ee~~~~~k   88 (184)
T PTZ00444         13 VFSYINFSACLLPWTKKRKAENQMGLIKDIAKELKLASETLPTPEQVSAKIHRIDKEVIKKLDKDIIKEENEDKKK   88 (184)
T ss_pred             HHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCHHHHHHHHHhcCHHHHHHHHHHHHHHHHHhhcc
Confidence            4566778888877766666677776666666555555556799999999999999999999999998865554444


No 6  
>COG2379 GckA Putative glycerate kinase [Carbohydrate transport and metabolism]
Probab=61.22  E-value=19  Score=34.81  Aligned_cols=77  Identities=32%  Similarity=0.382  Sum_probs=61.7

Q ss_pred             HHHhCC--CCCHHhHHHHHHHHhcCCChHHHHHHHHHHHhccCCCchHHHhh-hccc-ccccccCCCCCCCCCCCCCccc
Q 026073          158 VLLSLP--CITPQDLLAFEDALTKTASPREQKQHMRSLLVSGTGNNLKALAA-QKSV-NVITNVSTRPRSSDNAPENRTE  233 (244)
Q Consensus       158 vL~sLP--~I~~~~l~~f~~~L~~~~s~K~QR~l~~~LL~~~~g~~l~a~~~-~k~~-~~i~~v~~~~~~~~~~~~~~~~  233 (244)
                      -|+.+|  ||+-+|+......|.++..+=.-=+.+++=|..+||-.|.+.+. .|-. -+|.||---+.+. -+.|++..
T Consensus       125 aL~e~P~eGitL~d~~avn~~LL~sGA~I~emNtVRkhLS~VKGGrLA~a~~pA~VvsliiSDVpGDd~~~-IASGPTv~  203 (422)
T COG2379         125 ALLELPAEGITLEDLIAVNRALLKSGAPISEMNTVRKHLSRVKGGRLAAAAKPAKVVSLIISDVPGDDPSV-IASGPTVP  203 (422)
T ss_pred             hhccCCccCCCHHHHHHHHHHHHHcCCChHHHHHHHHHHhhccchHHHHhcCCCeEEEEEEccCCCCCHhh-cccCCCCC
Confidence            578899  99999999999999999888888999999999999999887763 3333 2778887777666 34466655


Q ss_pred             cc
Q 026073          234 EG  235 (244)
Q Consensus       234 ~~  235 (244)
                      |.
T Consensus       204 D~  205 (422)
T COG2379         204 DP  205 (422)
T ss_pred             CC
Confidence            43


No 7  
>KOG2022 consensus Nuclear transport receptor LGL2 (importin beta superfamily) [Nuclear structure; Intracellular trafficking, secretion, and vesicular transport]
Probab=60.86  E-value=98  Score=33.09  Aligned_cols=84  Identities=20%  Similarity=0.265  Sum_probs=57.9

Q ss_pred             HHHHHHHHHHHHhcccchHhhHHHHHHHHHHHHHHhcCCCccHHHHHH----hCC-----CCCHHhHHHHHHHHhcC-CC
Q 026073          113 VSKDLFSAIIRGLALESNAVISADLVGLCREIFIYMCDRDPAPRQVLL----SLP-----CITPQDLLAFEDALTKT-AS  182 (244)
Q Consensus       113 i~~ev~~a~L~~L~~~~f~d~q~eL~~L~~~Iy~~l~p~~~~pr~vL~----sLP-----~I~~~~l~~f~~~L~~~-~s  182 (244)
                      ++...+.+++.++.-.    .....+...++|.-.|-.++.+-....+    |.|     ||++++=++|-++|.+. .+
T Consensus       884 ~G~~Li~~im~~vgg~----~~RS~ld~~aDIL~al~~k~~se~r~wl~~~lq~~gfPs~~~s~e~k~rf~t~llrer~n  959 (982)
T KOG2022|consen  884 IGPILIYAIMRGVGGE----ASRSTLDALADILLALNAKFFSETRTWLKAVLQIPGFPSAGVSNEIKSRFVTSLLRERGN  959 (982)
T ss_pred             cchHHHHHHHHHhcCc----CccchhHHHHHHHHHHHHhhhHHHHHHHHHHhcCCCCCcccCChHHHHHHHHHHHHHHhc
Confidence            3556777777776333    2345566667777777777766544322    555     78888899999999665 55


Q ss_pred             hHHHHHHHHHHHhccCCC
Q 026073          183 PREQKQHMRSLLVSGTGN  200 (244)
Q Consensus       183 ~K~QR~l~~~LL~~~~g~  200 (244)
                      .|.-+++++++-..++|-
T Consensus       960 ~R~~k~~il~~~L~~~~l  977 (982)
T KOG2022|consen  960 KRNFKQQILEFNLACTGL  977 (982)
T ss_pred             HHHHHHHHHHHHHHhcCC
Confidence            688889999987777663


No 8  
>PF04675 DNA_ligase_A_N:  DNA ligase N terminus;  InterPro: IPR012308 DNA ligase (polydeoxyribonucleotide synthase) is the enzyme that joins two DNA fragments by catalysing the formation of an internucleotide ester bond between phosphate and deoxyribose. It is active during DNA replication, DNA repair and DNA recombination. There are two forms of DNA ligase, one requires ATP (6.5.1.1 from EC), the other NAD (6.5.1.2 from EC), the latter being restricted to eubacteria. Eukaryotic, archaebacterial, viral and some eubacterial DNA ligases are ATP-dependent. The first step in the ligation reaction is the formation of a covalent enzyme-AMP complex. The co-factor ATP is cleaved to pyrophosphate and AMP, with the AMP being covalently joined to a highly conserved lysine residue in the active site of the ligase. The activated AMP residue is then transferred to the 5'phosphate of the nick, before the nick is sealed by phosphodiester-bond formation and AMP elimination [,]. Vertebrate cells encode three well-characterised DNA ligases (DNA ligases I, III and IV), all of which are related in structure and sequence. With the exception of the atypically small PBCV-1 viral enzyme, two regions of primary sequence are common to all members of the family. The catalytic region comprises six conserved sequence motifs (I, III, IIIa, IV, V-VI), motif I includes the lysine residue that is adenylated in the first step of the ligation reaction. The function of the second, less well-conserved region is unknown. When folded, each protein comprises of two distinct sub-domains: a large amino-terminal sub-domain ('domain 1') and a smaller carboxy-terminal sub-domain ('domain 2'). The ATP-binding site of the enzyme lies in the cleft between the two sub-domains. Domain 1 consists of two antiparallel beta sheets flanked by alpha helices, whereas domain 2 consists of a five-stranded beta barrel and a single alpha helix, which form the oligonucleotide-binding fold [, ].  This region is found in many but not all ATP-dependent DNA ligase enzymes (6.5.1.1 from EC). It is thought to be involved in DNA binding and in catalysis. In human DNA ligase I (P18858 from SWISSPROT), and in Saccharomyces cerevisiae (Baker's yeast) (P04819 from SWISSPROT), this region was necessary for catalysis, and separated from the amino terminus by targeting elements. In Vaccinia virus (P16272 from SWISSPROT) this region was not essential for catalysis, but deletion decreases the affinity for nicked DNA and decreased the rate of strand joining at a step subsequent to enzyme-adenylate formation []. ; GO: 0003677 DNA binding, 0003910 DNA ligase (ATP) activity, 0006281 DNA repair, 0006310 DNA recombination; PDB: 2CFM_A 3RR5_A 2HIX_A 2HIV_A 3L2P_A 1X9N_A 4EQ5_A 3GDE_A.
Probab=54.69  E-value=29  Score=28.67  Aligned_cols=67  Identities=16%  Similarity=0.142  Sum_probs=47.0

Q ss_pred             HHHHHHHHHHHHHHhcCCCccHHHHHHhCCCCCHHhHHHHHHHHhcCC---ChHHHHHHHHHHHhccCCCchHHHhh
Q 026073          134 SADLVGLCREIFIYMCDRDPAPRQVLLSLPCITPQDLLAFEDALTKTA---SPREQKQHMRSLLVSGTGNNLKALAA  207 (244)
Q Consensus       134 q~eL~~L~~~Iy~~l~p~~~~pr~vL~sLP~I~~~~l~~f~~~L~~~~---s~K~QR~l~~~LL~~~~g~~l~a~~~  207 (244)
                      ..|+...+..++.........       -+.+|-.+|..+-++|++..   +...|++++.+|+..+...+.+-+.-
T Consensus        87 ~GD~g~~~~~~~~~~~~~~~~-------~~~lTi~~V~~~L~~la~~~g~~s~~~k~~~l~~ll~~~s~~E~k~i~R  156 (177)
T PF04675_consen   87 VGDLGEVAEEVLQKRKSETSK-------PSPLTISEVNETLDELAAASGKGSQDEKIDILKELLRRCSPEEAKWIVR  156 (177)
T ss_dssp             HS-HHHHHHHHHHHHTTTS---------SS--BHHHHHHHHHHHHH--STTHHHHHHHHHHHHHTTS-HHHHHHHHH
T ss_pred             cCcHHHHHHHHHhhccccccC-------CCCCCHHHHHHHHHHHHHhhCccchHHHHHHHHHHHHhCCHHHHHHHHH
Confidence            567777777777665533222       45778889999999998754   79999999999999999999888753


No 9  
>PF12717 Cnd1:  non-SMC mitotic condensation complex subunit 1
Probab=53.82  E-value=1.3e+02  Score=25.04  Aligned_cols=132  Identities=17%  Similarity=0.193  Sum_probs=72.4

Q ss_pred             hhhHHHHHhcCcccHHHHHHHHhhhhccccCcchhhhh-hhhhHHHHHHhccCchhHHHHHHHHHHHHHHHHhcccchHh
Q 026073           54 SKSMVGFLLKHKDLALPALQISLEAFTWTDGEAVTKVS-SFCSAVVLLAIQSNNIELQQFVSKDLFSAIIRGLALESNAV  132 (244)
Q Consensus        54 ~~~L~~~iL~~~~i~~plL~~~~~~l~wkDt~~~~~~~-sf~~~lv~~~i~~~~~~l~efi~~ev~~a~L~~L~~~~f~d  132 (244)
                      ...|+.++...+++++|.+-.....|.=.|.. +.+.+ ...+-|+.....    .+    -..+|...+..|.|+    
T Consensus         9 i~~l~DL~~r~~~~ve~~~~~l~~~L~D~~~~-VR~~al~~Ls~Li~~d~i----k~----k~~l~~~~l~~l~D~----   75 (178)
T PF12717_consen    9 IIALGDLCIRYPNLVEPYLPNLYKCLRDEDPL-VRKTALLVLSHLILEDMI----KV----KGQLFSRILKLLVDE----   75 (178)
T ss_pred             HHHHHHHHHhCcHHHHhHHHHHHHHHCCCCHH-HHHHHHHHHHHHHHcCce----ee----hhhhhHHHHHHHcCC----
Confidence            36789999999999999999999998855433 33332 333333322111    11    233445555666555    


Q ss_pred             hHHHHHHHHHHHHHHhcCC-Ccc-----HHHHHHhCC---------CCCHHhHHHHHHHHhcCCC-hHHHHHHHHHHHhc
Q 026073          133 ISADLVGLCREIFIYMCDR-DPA-----PRQVLLSLP---------CITPQDLLAFEDALTKTAS-PREQKQHMRSLLVS  196 (244)
Q Consensus       133 ~q~eL~~L~~~Iy~~l~p~-~~~-----pr~vL~sLP---------~I~~~~l~~f~~~L~~~~s-~K~QR~l~~~LL~~  196 (244)
                       ..+....+...+..+..+ ++.     .-+++..+.         +.+.++-...++.|.+--+ +|++-.++.+|...
T Consensus        76 -~~~Ir~~A~~~~~e~~~~~~~~~i~~~~~e~i~~l~~~~~~~~~~~~~~~~~~~I~~fll~~i~~d~~~~~l~~kl~~~  154 (178)
T PF12717_consen   76 -NPEIRSLARSFFSELLKKRNPNIIYNNFPELISSLNNCYEHPVYGPLSREKRKKIYKFLLDFIDKDKQKESLVEKLCQR  154 (178)
T ss_pred             -CHHHHHHHHHHHHHHHHhccchHHHHHHHHHHHHHhCccccccccccCHHHHHHHHHHHHHHcCcHHHHHHHHHHHHHH
Confidence             333444444444333322 222     122333332         2455566666666666444 77777777777666


Q ss_pred             cCC
Q 026073          197 GTG  199 (244)
Q Consensus       197 ~~g  199 (244)
                      ..+
T Consensus       155 ~~~  157 (178)
T PF12717_consen  155 FLN  157 (178)
T ss_pred             HHH
Confidence            533


No 10 
>cd00893 PI4Kc_III Phosphoinositide 4-kinase (PI4K), Type III, catalytic domain; The PI4K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases. PI4Ks catalyze the transfer of the gamma-phosphoryl group from ATP to the 4-hydroxyl of the inositol ring of D-myo-phosphatidylinositol (PtdIns) to generate PtdIns(4)P, the major precursor in the synthesis of other phosphoinositides including PtdIns(4,5)P2, PtdIns(3,4)P2, and PtdIns(3,4,5)P3. There are two types of PI4Ks, types II and III. Type II PI4Ks lack the characteristic catalytic kinase domain present in PI3Ks and type III PI4Ks, and are excluded from this family. Two isoforms of type III PI4K, alpha and beta, exist in most eukaryotes.
Probab=50.62  E-value=61  Score=29.89  Aligned_cols=86  Identities=15%  Similarity=0.171  Sum_probs=65.1

Q ss_pred             HHHHHHHHHHHHHHhcccchHhhHHHHHHHHHHHHHHhcCCCccHHHHHH-----hCCCCCHHhHHHHHHHHhcCCChHH
Q 026073          111 QFVSKDLFSAIIRGLALESNAVISADLVGLCREIFIYMCDRDPAPRQVLL-----SLPCITPQDLLAFEDALTKTASPRE  185 (244)
Q Consensus       111 efi~~ev~~a~L~~L~~~~f~d~q~eL~~L~~~Iy~~l~p~~~~pr~vL~-----sLP~I~~~~l~~f~~~L~~~~s~K~  185 (244)
                      .|.=+.-|-.++.+..    .+.......+|...|..+|......-.++.     .+|+.+.+++..+.+.+.=..++.+
T Consensus       182 PFrLT~emv~~mGg~~----s~~f~~F~~~c~~~~~~lR~~~~~il~ll~~m~~~~lp~~~~~~i~~l~~r~~l~~s~~~  257 (289)
T cd00893         182 AFKFTKEMVDFMGGKK----SDDFKKFRYLCLRGFIAVRKHMDLVISLVYLLIFSGLPCFRGSTIKKLKERLCLNMSEKE  257 (289)
T ss_pred             CeeecHHHHHHhCCCC----ChhHHHHHHHHHHHHHHHhhCHHHHHHHHHHHccCCCcccCHHHHHHHHHHcCCCCCHHH
Confidence            3444444445554443    234567888999999999987776666552     5799999999999999987789999


Q ss_pred             HHHHHHHHHhccCCC
Q 026073          186 QKQHMRSLLVSGTGN  200 (244)
Q Consensus       186 QR~l~~~LL~~~~g~  200 (244)
                      .+..|.+++....+.
T Consensus       258 a~~~~~~lI~~s~~~  272 (289)
T cd00893         258 AINTVMKKIDSSYNS  272 (289)
T ss_pred             HHHHHHHHHHHHHhh
Confidence            999999999988764


No 11 
>cd05174 PI3Kc_IA_delta Phosphoinositide 3-kinase (PI3K), class IA, delta isoform, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases. PI3Ks catalyze the transfer of the gamma-phosphoryl group from ATP to the 3-hydroxyl of the inositol ring of D-myo-phosphatidylinositol (PtdIns) or its derivatives. PI3Ks can be divided into three main classes (I, II, and III), defined by their substrate specificity, regulation, and domain structure. Class I PI3Ks are the only enzymes capable of converting PtdIns(4,5)P2 to the critical second messenger PtdIns(3,4,5)P3. Class I enzymes are heterodimers and exist in multiple isoforms consisting of one catalytic subunit (out of four isoforms) and one of several regulatory subunits. They are further classified into class IA (alpha, beta and 
Probab=50.21  E-value=46  Score=31.79  Aligned_cols=69  Identities=14%  Similarity=0.253  Sum_probs=56.2

Q ss_pred             hHHHHHHHHHHHHHHhcCCCccHHHHHH-----hCCCCCH-HhHHHHHHHHhcCCChHHHHHHHHHHHhccCCCc
Q 026073          133 ISADLVGLCREIFIYMCDRDPAPRQVLL-----SLPCITP-QDLLAFEDALTKTASPREQKQHMRSLLVSGTGNN  201 (244)
Q Consensus       133 ~q~eL~~L~~~Iy~~l~p~~~~pr~vL~-----sLP~I~~-~~l~~f~~~L~~~~s~K~QR~l~~~LL~~~~g~~  201 (244)
                      .....-.+|...|..+|......-.++.     .+|+++. +++..+.+.+.-..++.+...+|.+++..+.+.+
T Consensus       273 ~f~~F~~~c~~a~~~LRk~~~~il~l~~lM~~sgip~~~~~~~i~~l~~~~~l~~se~ea~~~f~~~i~~s~~~~  347 (361)
T cd05174         273 KFERFRGYCEQAYKILRRHGTLFLHLFALMKAAGLPELNCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRES  347 (361)
T ss_pred             hhhHHHHHHHHHHHHHHhhHHHHHHHHHHHhcCCCCccCchhHHHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhC
Confidence            4556788999999999977765555443     7899874 6899999999888999999999999998886555


No 12 
>cd05168 PI4Kc_III_beta Phosphoinositide 4-kinase (PI4K), Type III, beta isoform, catalytic domain; The PI4K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases. PI4Ks catalyze the transfer of the gamma-phosphoryl group from ATP to the 4-hydroxyl of the inositol ring of D-myo-phosphatidylinositol (PtdIns) to generate PtdIns(4)P, the major precursor in the synthesis of other phosphoinositides including PtdIns(4,5)P2, PtdIns(3,4)P2, and PtdIns(3,4,5)P3. Two isoforms of type III PI4K, alpha and beta, exist in most eukaryotes. PI4KIIIbeta (also called Pik1p in yeast) is a 110 kDa protein that is localized to the Golgi and the nucleus. It is required for maintaining the structural integrity of the Golgi complex (GC), and is a key regulator of protein transport from the GC to the plasma membrane. PI4KII
Probab=47.50  E-value=65  Score=29.78  Aligned_cols=69  Identities=12%  Similarity=0.141  Sum_probs=57.0

Q ss_pred             hhHHHHHHHHHHHHHHhcCCCccHHHHH---H---hCCCCC--HHhHHHHHHHHhcCCChHHHHHHHHHHHhccCCC
Q 026073          132 VISADLVGLCREIFIYMCDRDPAPRQVL---L---SLPCIT--PQDLLAFEDALTKTASPREQKQHMRSLLVSGTGN  200 (244)
Q Consensus       132 d~q~eL~~L~~~Iy~~l~p~~~~pr~vL---~---sLP~I~--~~~l~~f~~~L~~~~s~K~QR~l~~~LL~~~~g~  200 (244)
                      +.......+|...|..+|......-.++   .   .+|..+  .+++..+.+.+.-..++++....|.+++..+.+.
T Consensus       200 ~~~~~F~~~c~~~~~~LR~~~~~il~ll~~m~~~~~lp~f~~~~~~i~~l~~r~~l~~se~~a~~~~~~lI~~s~~~  276 (293)
T cd05168         200 DLFNYFKKLFLKGFMALRKHVDRIILLVEIMQSDSKLPCFKAGEFTIQQLRDRFMLNLTEEQLEVFVDELINQSLDN  276 (293)
T ss_pred             chhHHHHHHHHHHHHHHHhchHHHHHHHHHHccCCCCccccCchHHHHHHHHHhCCCCCHHHHHHHHHHHHHHHHhc
Confidence            3567788999999999998877665544   3   467777  7799999999988889999999999999998765


No 13 
>PF05004 IFRD:  Interferon-related developmental regulator (IFRD);  InterPro: IPR007701 Interferon-related developmental regulator (IFRD1) is the human homologue of the Rattus norvegicus early response protein PC4 and its murine homologue TIS7 []. The exact function of IFRD1 is unknown but it has been shown that PC4 is necessary for muscle differentiation and that it might have a role in signal transduction. This entry also contains IFRD2 and its murine equivalent SKMc15, which are highly expressed soon after gastrulation and in the hepatic primordium, suggesting an involvement in early hematopoiesis [].
Probab=46.82  E-value=2.4e+02  Score=26.04  Aligned_cols=95  Identities=13%  Similarity=0.166  Sum_probs=55.4

Q ss_pred             hhhhHHHHHHhccCchhHHHHHHHHHHHHHHHHhcccchHhhHHHHHHHHHHHHHHhcCCCccHHHHHHhCCCCCHHhHH
Q 026073           92 SFCSAVVLLAIQSNNIELQQFVSKDLFSAIIRGLALESNAVISADLVGLCREIFIYMCDRDPAPRQVLLSLPCITPQDLL  171 (244)
Q Consensus        92 sf~~~lv~~~i~~~~~~l~efi~~ev~~a~L~~L~~~~f~d~q~eL~~L~~~Iy~~l~p~~~~pr~vL~sLP~I~~~~l~  171 (244)
                      ...+|-.+..... +..+. -...+.++.+.. |-+...++.+-....-|+.||+..+......     .-|  +.++|-
T Consensus       206 AL~aW~lLlt~~~-~~~~~-~~~~~~~~~l~~-lL~s~d~~VRiAAGEaiAll~E~~~~~~~~~-----~~~--~~~~l~  275 (309)
T PF05004_consen  206 ALSAWALLLTTLP-DSKLE-DLLEEALPALSE-LLDSDDVDVRIAAGEAIALLYELARDHEEDF-----LYE--DMEELL  275 (309)
T ss_pred             HHHHHHHHHhcCC-HHHHH-HHHHHHHHHHHH-HhcCCCHHHHHHHHHHHHHHHHHhhcccccc-----ccc--CHHHHH
Confidence            5556655544332 22344 233444554434 3345578899999999999999988543331     011  444444


Q ss_pred             HHHHHHhcC-------CChHHHHHHHHHHHhc
Q 026073          172 AFEDALTKT-------ASPREQKQHMRSLLVS  196 (244)
Q Consensus       172 ~f~~~L~~~-------~s~K~QR~l~~~LL~~  196 (244)
                      +--..|..-       +.-|+||..|++++.-
T Consensus       276 ~~l~~La~dS~K~~sKkdrk~qRs~Frdil~~  307 (309)
T PF05004_consen  276 EQLRELATDSSKSRSKKDRKQQRSSFRDILTT  307 (309)
T ss_pred             HHHHHHHHhccCccchhHHHHHHHHHHHHHHh
Confidence            444444331       2278999999998864


No 14 
>PRK14707 hypothetical protein; Provisional
Probab=44.23  E-value=1.5e+02  Score=35.02  Aligned_cols=124  Identities=15%  Similarity=0.197  Sum_probs=77.9

Q ss_pred             hhHHHHHhcCcccHH---H-HHHHHhhhhc-cccCcchhhhhhhhhHHHHHHhccCchhHHHHHHHHHHHHHHHHh-ccc
Q 026073           55 KSMVGFLLKHKDLAL---P-ALQISLEAFT-WTDGEAVTKVSSFCSAVVLLAIQSNNIELQQFVSKDLFSAIIRGL-ALE  128 (244)
Q Consensus        55 ~~L~~~iL~~~~i~~---p-lL~~~~~~l~-wkDt~~~~~~~sf~~~lv~~~i~~~~~~l~efi~~ev~~a~L~~L-~~~  128 (244)
                      +.|...+-.+.+.+.   | =+...+++++ |.||+.|+.+......     -+..+..++.-+-..-+..||++| --|
T Consensus       438 ~~lA~~la~d~~l~~~~~p~~va~~LnalSKWPd~p~c~~aa~~La~-----~l~~~~~l~~a~~~q~~~~~L~aLSK~P  512 (2710)
T PRK14707        438 SALAGRLAHDTELCKALDPINVTQALDALSKWPDTPICGQTASALAA-----RLAHERRLRKALKPQEVVIALHSLSKWP  512 (2710)
T ss_pred             HHHHHHHhccHHHHhhcChHHHHHHHHHhhcCCCChhHHHHHHHHHH-----HhcccHHHHhhcCHHHHHHHHHHhhcCC
Confidence            345555555555542   1 1445667776 9999999998853222     223466688888888889999999 445


Q ss_pred             chHhhHHHHHHHHHHHHHHhcCCCccHHHHHHhCCCC-CHHhHHHHHHHHhcCCChHHHHHHHHHHHh
Q 026073          129 SNAVISADLVGLCREIFIYMCDRDPAPRQVLLSLPCI-TPQDLLAFEDALTKTASPREQKQHMRSLLV  195 (244)
Q Consensus       129 ~f~d~q~eL~~L~~~Iy~~l~p~~~~pr~vL~sLP~I-~~~~l~~f~~~L~~~~s~K~QR~l~~~LL~  195 (244)
                      -+..|...+..++.++-.   +.         ++|.. +.+.+..+-..|.+-......|..+..+-.
T Consensus       513 d~~~c~~A~~~lA~rl~~---~~---------~l~~~~~~~~~~~~lnalSKwp~s~~C~~A~~~iA~  568 (2710)
T PRK14707        513 DTPICAEAASALAERVVD---EL---------QLRKAFDAHQVVNTLKALSKWPDKQLCAVAASGLAE  568 (2710)
T ss_pred             CcHHHHHHHHHHHHHhcc---ch---------hhhhhhhhHHHHHHHHhhhcCCchhHHHHHHHHHHH
Confidence            555688888888777651   11         33433 777777777778664333344444444443


No 15 
>cd00891 PI3Kc Phosphoinositide 3-kinase (PI3K), catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases. PI3Ks catalyze the transfer of the gamma-phosphoryl group from ATP to the 3-hydroxyl of the inositol ring of D-myo-phosphatidylinositol (PtdIns) or its derivatives. PI3Ks play an important role in a variety of fundamental cellular processes, including cell motility, the Ras pathway, vesicle trafficking and secretion, immune cell activation and apoptosis. They can be divided into three main classes (I, II, and III), defined by their substrate specificity, regulation, and domain structure. Class I PI3Ks are the only enzymes capable of converting PtdIns(4,5)P2 to the critical second messenger PtdIns(3,4,5)P3. Class I enzymes are heterodimers and exist in multiple isoforms c
Probab=42.37  E-value=94  Score=29.43  Aligned_cols=88  Identities=17%  Similarity=0.233  Sum_probs=64.6

Q ss_pred             HHHHHHHHHHHHHHhcccchHhhHHHHHHHHHHHHHHhcCCCccHHHHHH-----hCCCCCH-HhHHHHHHHHhcCCChH
Q 026073          111 QFVSKDLFSAIIRGLALESNAVISADLVGLCREIFIYMCDRDPAPRQVLL-----SLPCITP-QDLLAFEDALTKTASPR  184 (244)
Q Consensus       111 efi~~ev~~a~L~~L~~~~f~d~q~eL~~L~~~Iy~~l~p~~~~pr~vL~-----sLP~I~~-~~l~~f~~~L~~~~s~K  184 (244)
                      .|.=+.-|-.++.+...+    .......+|...|..+|......-.++.     .+|++++ +++..+.+.|.-..+++
T Consensus       247 PFrLT~~mv~~mGg~~s~----~~~~F~~~c~~~~~~LR~~~~~il~l~~lm~~~~lp~~~~~~~i~~l~~r~~l~~s~~  322 (352)
T cd00891         247 PFVLTPDMAYVMGGGDSE----KFQRFEDLCCKAYNILRKHGNLFINLFSLMLSAGIPELQSIEDIEYLRDALALDKSDE  322 (352)
T ss_pred             CeeecHHHHHHhCCCCCc----ccchHHHHHHHHHHHHhcCHHHHHHHHHhhccCCCCccCcHHHHHHHHHHhCCCCCHH
Confidence            344444444555544322    3456778888999999977776666543     3899885 69999999998889999


Q ss_pred             HHHHHHHHHHhccCCCch
Q 026073          185 EQKQHMRSLLVSGTGNNL  202 (244)
Q Consensus       185 ~QR~l~~~LL~~~~g~~l  202 (244)
                      +....|.+++....+.--
T Consensus       323 ~a~~~~~~lI~~s~~~~~  340 (352)
T cd00891         323 EATEYFRKLIHESLNSKT  340 (352)
T ss_pred             HHHHHHHHHHHHHHhcch
Confidence            999999999998876653


No 16 
>cd05166 PI3Kc_II Phosphoinositide 3-kinase (PI3K), class II, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases. PI3Ks catalyze the transfer of the gamma-phosphoryl group from ATP to the 3-hydroxyl of the inositol ring of D-myo-phosphatidylinositol (PtdIns) or its derivatives. PI3Ks play an important role in a variety of fundamental cellular processes, including cell motility, the Ras pathway, vesicle trafficking and secretion, immune cell activation and apoptosis. They can be divided into three main classes (I, II, and III), defined by their substrate specificity, regulation, and domain structure. Class II PI3Ks preferentially use PtdIns as a substrate to produce PtdIns(3)P, but can also phosphorylate PtdIns(4)P. They function as monomers and do not associate with any
Probab=41.58  E-value=1.1e+02  Score=28.93  Aligned_cols=70  Identities=23%  Similarity=0.292  Sum_probs=56.9

Q ss_pred             hhHHHHHHHHHHHHHHhcCCCccHHHHHH-----hCCCCC-HHhHHHHHHHHhcCCChHHHHHHHHHHHhccCCCc
Q 026073          132 VISADLVGLCREIFIYMCDRDPAPRQVLL-----SLPCIT-PQDLLAFEDALTKTASPREQKQHMRSLLVSGTGNN  201 (244)
Q Consensus       132 d~q~eL~~L~~~Iy~~l~p~~~~pr~vL~-----sLP~I~-~~~l~~f~~~L~~~~s~K~QR~l~~~LL~~~~g~~  201 (244)
                      +.......+|...|..+|......-.++.     .||+++ .+++..+.+.+.-..++.+....|.+++....+.-
T Consensus       265 ~~~~~F~~~c~~~~~~lRk~~~~il~ll~~ml~s~lp~~~~~~~i~~l~~r~~l~~s~~ea~~~~~~~I~~s~~s~  340 (353)
T cd05166         265 QRFQDFVDLCCRAYNIIRKHANLLLNLLRMMACSGLPELSKIQDLKYVRDALRPQLTDAEATIQFTKMIQSSLGSA  340 (353)
T ss_pred             chHhHHHHHHHHHHHHHHcChHHHHHHHHHHhcCCCcccCchhHHHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhh
Confidence            35567888899999999977776655443     478988 77999999999888899999999999999887543


No 17 
>cd00895 PI3Kc_C2_beta Phosphoinositide 3-kinase (PI3K), class II, beta isoform, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases. PI3Ks catalyze the transfer of the gamma-phosphoryl group from ATP to the 3-hydroxyl of the inositol ring of D-myo-phosphatidylinositol (PtdIns) or its derivatives. PI3Ks play an important role in a variety of fundamental cellular processes, including cell motility, the Ras pathway, vesicle trafficking and secretion, immune cell activation and apoptosis. They can be divided into three main classes (I, II, and III), defined by their substrate specificity, regulation, and domain structure. Class II PI3Ks preferentially use PtdIns as a substrate to produce PtdIns(3)P, but can also phosphorylate PtdIns(4)P. They function as monomers and do not
Probab=41.58  E-value=75  Score=30.29  Aligned_cols=71  Identities=20%  Similarity=0.280  Sum_probs=57.1

Q ss_pred             hhHHHHHHHHHHHHHHhcCCCccHHH---HHH--hCCCCCH-HhHHHHHHHHhcCCChHHHHHHHHHHHhccCCCch
Q 026073          132 VISADLVGLCREIFIYMCDRDPAPRQ---VLL--SLPCITP-QDLLAFEDALTKTASPREQKQHMRSLLVSGTGNNL  202 (244)
Q Consensus       132 d~q~eL~~L~~~Iy~~l~p~~~~pr~---vL~--sLP~I~~-~~l~~f~~~L~~~~s~K~QR~l~~~LL~~~~g~~l  202 (244)
                      +.......+|...|..+|......-.   .|.  .+|+++. +++..+.+.+.-..++.+...+|.+++....+.-.
T Consensus       266 ~~f~~F~~lc~~ay~~lRk~~~~il~L~~lM~~sgiP~l~~~~~i~~l~~rf~l~~se~eA~~~f~~lI~~s~~s~~  342 (354)
T cd00895         266 SRFHDFVDLCCQAYNLIRKHTHLFLNLLGLMLSCGIPELSDLEDLKYVYDALRPQDTEADATTYFTRLIESSLGSVA  342 (354)
T ss_pred             hhHHHHHHHHHHHHHHHHHhHHHHHHHHHHHHcCCCcccCcchHHHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhh
Confidence            45677889999999999977765544   333  5899975 58999999998888999999999999998876433


No 18 
>cd05176 PI3Kc_C2_alpha Phosphoinositide 3-kinase (PI3K), class II, alpha isoform, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases. PI3Ks catalyze the transfer of the gamma-phosphoryl group from ATP to the 3-hydroxyl of the inositol ring of D-myo-phosphatidylinositol (PtdIns) or its derivatives. PI3Ks play an important role in a variety of fundamental cellular processes, including cell motility, the Ras pathway, vesicle trafficking and secretion, immune cell activation and apoptosis. They can be divided into three main classes (I, II, and III), defined by their substrate specificity, regulation, and domain structure. Class II PI3Ks preferentially use PtdIns as a substrate to produce PtdIns(3)P, but can also phosphorylate PtdIns(4)P. They function as monomers and do n
Probab=41.41  E-value=93  Score=29.65  Aligned_cols=71  Identities=24%  Similarity=0.251  Sum_probs=55.7

Q ss_pred             hHHHHHHHHHHHHHHhcCCCccHHHHH---H--hCCCCCH-HhHHHHHHHHhcCCChHHHHHHHHHHHhccCCCchH
Q 026073          133 ISADLVGLCREIFIYMCDRDPAPRQVL---L--SLPCITP-QDLLAFEDALTKTASPREQKQHMRSLLVSGTGNNLK  203 (244)
Q Consensus       133 ~q~eL~~L~~~Iy~~l~p~~~~pr~vL---~--sLP~I~~-~~l~~f~~~L~~~~s~K~QR~l~~~LL~~~~g~~l~  203 (244)
                      .......+|...|..+|......-.++   .  .+|+++. +++..+.+.+.-..++.+....|.++|....+.-..
T Consensus       266 ~f~~F~~lc~~af~~LRk~~~~il~L~~lM~~s~iP~~~~~~~i~~l~~r~~l~~sd~ea~~~f~~lI~~s~~s~~t  342 (353)
T cd05176         266 RFQLFVDLCCQAYNLIRKHSNLFLNLLSLMTQSGLPELTGVQDLKYVYDALQPQTTDAEATIFFTRLIESSLGSVAT  342 (353)
T ss_pred             hHHHHHHHHHHHHHHHHHhHHHHHHHHHHHhCCCCcccCCchHHHHHHHHhCCCCCHHHHHHHHHHHHHHHHhchhH
Confidence            456678899999999997776544433   2  5898875 689999999988889999999999999988765433


No 19 
>cd05165 PI3Kc_I Phosphoinositide 3-kinase (PI3K), class I, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases. PI3Ks catalyze the transfer of the gamma-phosphoryl group from ATP to the 3-hydroxyl of the inositol ring of D-myo-phosphatidylinositol (PtdIns) or its derivatives. PI3Ks play an important role in a variety of fundamental cellular processes, including cell motility, the Ras pathway, vesicle trafficking and secretion, immune cell activation and apoptosis. They can be divided into three main classes (I, II, and III), defined by their substrate specificity, regulation, and domain structure. Class I PI3Ks are the only enzymes capable of converting PtdIns(4,5)P2 to the critical second messenger PtdIns(3,4,5)P3. In vitro, they can also phosphorylate the substrates P
Probab=41.37  E-value=83  Score=30.07  Aligned_cols=71  Identities=14%  Similarity=0.184  Sum_probs=56.1

Q ss_pred             HhhHHHHHHHHHHHHHHhcCCCccHHHH---H--HhCCCCC-HHhHHHHHHHHhcCCChHHHHHHHHHHHhccCCCc
Q 026073          131 AVISADLVGLCREIFIYMCDRDPAPRQV---L--LSLPCIT-PQDLLAFEDALTKTASPREQKQHMRSLLVSGTGNN  201 (244)
Q Consensus       131 ~d~q~eL~~L~~~Iy~~l~p~~~~pr~v---L--~sLP~I~-~~~l~~f~~~L~~~~s~K~QR~l~~~LL~~~~g~~  201 (244)
                      .+.....-.+|...|..+|......-.+   |  ..+|+++ .+++..+.+.+.=..++.+....|.+++..+.+.+
T Consensus       276 s~~f~~F~~~c~~a~~~LR~~~~~il~l~~lM~~s~ip~~~~~~~i~~lr~rf~l~~se~eA~~~f~~~I~~s~~~~  352 (366)
T cd05165         276 SEHFQRFQDLCEKAYLALRRHGNLLIILFSMMLMSGLPELTSKEDIEYLRDTLALGKSEEEALKYFLDKFNEALDGS  352 (366)
T ss_pred             ChhhhHHHHHHHHHHHHHHhCHHHHHHHHHHHhcCCCcccCchhHHHHHHHHhCCCCCHHHHHHHHHHHHHHHHhcC
Confidence            3456778889999999999776544433   3  2589888 66999999999888899999999999999886544


No 20 
>cd00896 PI3Kc_III Phosphoinositide 3-kinase (PI3K), class III, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases. PI3Ks catalyze the transfer of the gamma-phosphoryl group from ATP to the 3-hydroxyl of the inositol ring of D-myo-phosphatidylinositol (PtdIns) or its derivatives. PI3Ks play an important role in a variety of fundamental cellular processes, including cell motility, the Ras pathway, vesicle trafficking and secretion, immune cell activation and apoptosis. They can be divided into three main classes (I, II, and III), defined by their substrate specificity, regulation, and domain structure. Class III PI3Ks, also called Vps34 (vacuolar protein sorting 34), contain an N-terminal lipid binding C2 domain, a PI3K homology domain of unknown function, and a C-termin
Probab=40.53  E-value=1.1e+02  Score=29.06  Aligned_cols=73  Identities=12%  Similarity=0.227  Sum_probs=57.4

Q ss_pred             hHHHHHHHHHHHHHHhcCCCccHHHHHH-----hCCCCC---HHhHHHHHHHHhcCCChHHHHHHHHHHHhccCCCchHH
Q 026073          133 ISADLVGLCREIFIYMCDRDPAPRQVLL-----SLPCIT---PQDLLAFEDALTKTASPREQKQHMRSLLVSGTGNNLKA  204 (244)
Q Consensus       133 ~q~eL~~L~~~Iy~~l~p~~~~pr~vL~-----sLP~I~---~~~l~~f~~~L~~~~s~K~QR~l~~~LL~~~~g~~l~a  204 (244)
                      .......+|...|..+|......-.++.     .+|+++   .+++..+.+++.-..++++..+.|.+++....+.-...
T Consensus       259 ~~~~F~~~c~~~~~~lR~~~~~il~l~~lm~~~~ip~~~~~~~~~i~~l~~rf~l~~s~~ea~~~~~~lI~~s~~~~~t~  338 (350)
T cd00896         259 GYQEFKSYCCEAYNILRKSANLILNLFSLMVDANIPDIALDPDKAILKVQEKFRLDLSDEEAIKHFQNLINDSVNALFPV  338 (350)
T ss_pred             chHHHHHHHHHHHHHHHhCHHHHHHHHHHHcCCCCcccccCHHHHHHHHHHHhCCCCCHHHHHHHHHHHHHHHHhhhHHH
Confidence            4457788899999999987766655443     388887   56899999999888889999999999999877665443


Q ss_pred             H
Q 026073          205 L  205 (244)
Q Consensus       205 ~  205 (244)
                      +
T Consensus       339 ~  339 (350)
T cd00896         339 V  339 (350)
T ss_pred             H
Confidence            3


No 21 
>PRK10702 endonuclease III; Provisional
Probab=39.69  E-value=1e+02  Score=26.92  Aligned_cols=57  Identities=14%  Similarity=0.208  Sum_probs=38.4

Q ss_pred             HHHHHHHHHHHhcccchHhhHHHHHHHHHHHHHHhcCCCccHHHHHHhCCCCCHHhHHH
Q 026073          114 SKDLFSAIIRGLALESNAVISADLVGLCREIFIYMCDRDPAPRQVLLSLPCITPQDLLA  172 (244)
Q Consensus       114 ~~ev~~a~L~~L~~~~f~d~q~eL~~L~~~Iy~~l~p~~~~pr~vL~sLP~I~~~~l~~  172 (244)
                      ..+=+..+|+++.  |+.-=-+-|..++..|...+....|..++-|++||||-++--+-
T Consensus        68 ~~~~l~~~i~~~G--~y~~kA~~l~~~a~~i~~~~~~~~p~~~~~Ll~lpGVG~ktA~~  124 (211)
T PRK10702         68 GVEGVKTYIKTIG--LYNSKAENVIKTCRILLEQHNGEVPEDRAALEALPGVGRKTANV  124 (211)
T ss_pred             CHHHHHHHHHHcC--CHHHHHHHHHHHHHHHHHHcCCCCCchHHHHhcCCcccHHHHHH
Confidence            3455677777663  22111223666666676777778899999999999999985444


No 22 
>cd05177 PI3Kc_C2_gamma Phosphoinositide 3-kinase (PI3K), class II, gamma isoform, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases. PI3Ks catalyze the transfer of the gamma-phosphoryl group from ATP to the 3-hydroxyl of the inositol ring of D-myo-phosphatidylinositol (PtdIns) or its derivatives. PI3Ks play an important role in a variety of fundamental cellular processes, including cell motility, the Ras pathway, vesicle trafficking and secretion, immune cell activation and apoptosis. They can be divided into three main classes (I, II, and III), defined by their substrate specificity, regulation, and domain structure. Class II PI3Ks preferentially use PtdIns as a substrate to produce PtdIns(3)P, but can also phosphorylate PtdIns(4)P. They function as monomers and do n
Probab=37.66  E-value=84  Score=29.90  Aligned_cols=67  Identities=16%  Similarity=0.160  Sum_probs=54.1

Q ss_pred             hHHHHHHHHHHHHHHhcCCCccHHHHHH-----hCCCCCH-HhHHHHHHHHhcCCChHHHHHHHHHHHhccCC
Q 026073          133 ISADLVGLCREIFIYMCDRDPAPRQVLL-----SLPCITP-QDLLAFEDALTKTASPREQKQHMRSLLVSGTG  199 (244)
Q Consensus       133 ~q~eL~~L~~~Iy~~l~p~~~~pr~vL~-----sLP~I~~-~~l~~f~~~L~~~~s~K~QR~l~~~LL~~~~g  199 (244)
                      .......+|...|..+|......-.++.     .+|+++. +++..+.+.++=..++.+....|.+++....+
T Consensus       267 ~f~~F~~~c~~a~~~lR~~~~~il~l~~lm~~s~iP~~~~~~~i~~l~~~~~l~~sd~eA~~~f~~lI~~s~~  339 (354)
T cd05177         267 RFQRFVELCCRAYNIVRKHSQLLLNLLEMMLHAGLPELKDIQDLKYVYNNLRPQDTDLEATSYFTKKIKESLE  339 (354)
T ss_pred             hHHHHHHHHHHHHHHHHhhHHHHHHHHHHHhcCCCcccCcchHHHHHHHHhCCCCCHHHHHHHHHHHHHHHHh
Confidence            4456677888888888877766555433     6899976 58999999998889999999999999998875


No 23 
>PF12783 Sec7_N:  Guanine nucleotide exchange factor in Golgi transport N-terminal
Probab=37.19  E-value=1.4e+02  Score=24.46  Aligned_cols=78  Identities=15%  Similarity=0.130  Sum_probs=46.6

Q ss_pred             hhHHHHHHHHHHHHHHHHhcccchHhhHHHHHHHHHHHHHHhcCCCccHHHHHHhCCCCCHHhHHHHHHHH----hcC-C
Q 026073          107 IELQQFVSKDLFSAIIRGLALESNAVISADLVGLCREIFIYMCDRDPAPRQVLLSLPCITPQDLLAFEDAL----TKT-A  181 (244)
Q Consensus       107 ~~l~efi~~ev~~a~L~~L~~~~f~d~q~eL~~L~~~Iy~~l~p~~~~pr~vL~sLP~I~~~~l~~f~~~L----~~~-~  181 (244)
                      +.+..-+..++++++++.+..+. .....-.+.++..+|..+++.-..              +++-|-..+    .++ .
T Consensus        64 ~~l~~~lk~~l~~~Ll~~~~~~~-~~i~~~slri~~~l~~~~~~~Lk~--------------ele~~l~~i~~~il~~~~  128 (168)
T PF12783_consen   64 PSLINLLKDDLCPALLKNLSSSD-FPIFSRSLRIFLTLLSRFRSHLKL--------------ELEVFLSHIILRILESDN  128 (168)
T ss_pred             HHHHHHHHHHHHHHHHHHHhhhh-hHHHHHHHHHHHHHHHHHHHHHHH--------------HHHHHHHHHHHHHHccCC
Confidence            35566666777777776554444 335556777888888777644222              233333333    232 2


Q ss_pred             ChHHHHHHHHHHHhccCC
Q 026073          182 SPREQKQHMRSLLVSGTG  199 (244)
Q Consensus       182 s~K~QR~l~~~LL~~~~g  199 (244)
                      +.-.||.++++.+...-.
T Consensus       129 ~~~~~k~~~Le~l~~l~~  146 (168)
T PF12783_consen  129 SSLWQKELALEILRELCK  146 (168)
T ss_pred             CcHHHHHHHHHHHHHHHh
Confidence            245699999999887643


No 24 
>KOG2020 consensus Nuclear transport receptor CRM1/MSN5 (importin beta superfamily) [Nuclear structure; Intracellular trafficking, secretion, and vesicular transport]
Probab=36.59  E-value=91  Score=33.92  Aligned_cols=25  Identities=32%  Similarity=0.079  Sum_probs=18.9

Q ss_pred             hhhHHHHHHHHHHHHHHHHhcCCCC
Q 026073            2 EEKLLRDLTREICSLLSTMASSGLN   26 (244)
Q Consensus         2 eE~lLRqLTr~vv~ll~~~~~p~~~   26 (244)
                      |++.-+-+++++..+....+..+.+
T Consensus       829 e~~~~f~~lle~l~~~~~~~~~~l~  853 (1041)
T KOG2020|consen  829 EHRLNFLLLLEALLLFCFPAFSELP  853 (1041)
T ss_pred             HHHHHHHHHHHHHHHhhhHHHHcCC
Confidence            6778888999999888666665543


No 25 
>cd00894 PI3Kc_IB_gamma Phosphoinositide 3-kinase (PI3K), class IB, gamma isoform, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases. PI3Ks catalyze the transfer of the gamma-phosphoryl group from ATP to the 3-hydroxyl of the inositol ring of D-myo-phosphatidylinositol (PtdIns) or its derivatives. PI3Ks can be divided into three main classes (I, II, and III), defined by their substrate specificity, regulation, and domain structure. Class I PI3Ks are the only enzymes capable of converting PtdIns(4,5)P2 to the critical second messenger PtdIns(3,4,5)P3. Class I enzymes are heterodimers and exist in multiple isoforms consisting of one catalytic subunit (out of four isoforms) and one of several regulatory subunits. They are further classified into class IA (alpha, beta and 
Probab=36.02  E-value=95  Score=29.71  Aligned_cols=69  Identities=16%  Similarity=0.255  Sum_probs=54.6

Q ss_pred             hhHHHHHHHHHHHHHHhcCCCccHHH---HH--HhCCCCC-HHhHHHHHHHHhcCCChHHHHHHHHHHHhccCCC
Q 026073          132 VISADLVGLCREIFIYMCDRDPAPRQ---VL--LSLPCIT-PQDLLAFEDALTKTASPREQKQHMRSLLVSGTGN  200 (244)
Q Consensus       132 d~q~eL~~L~~~Iy~~l~p~~~~pr~---vL--~sLP~I~-~~~l~~f~~~L~~~~s~K~QR~l~~~LL~~~~g~  200 (244)
                      +.......+|...|..+|......-.   .|  ..+|+++ .+++..+.+.|.-..|+.+..++|+++|..+...
T Consensus       276 ~~f~~F~~~c~~a~~~LRk~~~lil~L~~lM~~sgip~l~~~~~i~~l~~~~~l~~se~eA~~~f~~~I~~s~~~  350 (365)
T cd00894         276 LHFQKFQDVCVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKSEEDAKKHFLDQIEVCRDK  350 (365)
T ss_pred             hhHHHHHHHHHHHHHHHHhhHHHHHHHHHHHhcCCCcccCcchHHHHHHHHhCCCCCHHHHHHHHHHHHHHHHhc
Confidence            34567888999999999976654433   33  2588887 4689999999988899999999999999987544


No 26 
>PF02637 GatB_Yqey:  GatB domain;  InterPro: IPR018027 The GatB domain, the function of which is uncertain, is associated with aspartyl/glutamyl amidotransferase subunit B and glutamyl amidotransferase subunit E. These are involved in the formation of correctly charged Asn-tRNA(Asn) or Gln-tRNA(Gln) through the transamidation of misacylated Asp-tRNA(Asn) or Glu-tRNA(Gln) in organisms which lack either or both of asparaginyl-tRNA or glutaminyl-tRNA synthetases. The reaction takes place in the presence of glutamine and ATP through an activated phospho-Asp-tRNA(Asn) or phospho-Glu-tRNA(Gln). ; GO: 0016884 carbon-nitrogen ligase activity, with glutamine as amido-N-donor; PDB: 2D6F_D 3H0M_H 3H0R_K 3H0L_K 3KFU_F 3AL0_B 3IP4_B 2DF4_B 2G5I_B 2F2A_B ....
Probab=33.81  E-value=2.5e+02  Score=22.59  Aligned_cols=51  Identities=22%  Similarity=0.376  Sum_probs=36.7

Q ss_pred             CCCHHhHHHHHHHHhc-CCChHHHHHHHHHHHhccCCCchHHHhhhcccccccc
Q 026073          164 CITPQDLLAFEDALTK-TASPREQKQHMRSLLVSGTGNNLKALAAQKSVNVITN  216 (244)
Q Consensus       164 ~I~~~~l~~f~~~L~~-~~s~K~QR~l~~~LL~~~~g~~l~a~~~~k~~~~i~~  216 (244)
                      .|+++++..+-..+.+ .-+.+.-|.++..++..  |.+..++.+......+.+
T Consensus        39 ~i~~~~l~~li~l~~~~~Is~~~ak~ll~~~~~~--~~~~~~ii~~~~l~~i~d   90 (148)
T PF02637_consen   39 PISPEHLAELINLLEDGKISKKSAKELLRELLEN--GKSPEEIIEENGLWQISD   90 (148)
T ss_dssp             SSTHHHHHHHHHHHHTTSSGHHHHHHHHHHHHHH--TS-HHHHHHHTT---B--
T ss_pred             CCCHHHHHHHHHHHHcCCCCHHHHHHHHHHHHHc--CCCHHHHHHHcCCCcCCC
Confidence            5899999999988866 45577788888888877  888888888776666654


No 27 
>PRK09614 nrdF ribonucleotide-diphosphate reductase subunit beta; Reviewed
Probab=33.45  E-value=1.5e+02  Score=27.20  Aligned_cols=70  Identities=10%  Similarity=0.118  Sum_probs=54.6

Q ss_pred             CchhHHHHHHHHHHHHHHHHhcccchHhhHHHHHHHHHHHHHHhcCCCccHHHHHHhCCCCCHHhHHHHHHHHhc
Q 026073          105 NNIELQQFVSKDLFSAIIRGLALESNAVISADLVGLCREIFIYMCDRDPAPRQVLLSLPCITPQDLLAFEDALTK  179 (244)
Q Consensus       105 ~~~~l~efi~~ev~~a~L~~L~~~~f~d~q~eL~~L~~~Iy~~l~p~~~~pr~vL~sLP~I~~~~l~~f~~~L~~  179 (244)
                      .|..++-.++..+++..++-..+....+.+.++..++.+.|..   .....+.++- +.| +.+++.+|.+..++
T Consensus       196 RDE~~H~~f~~~l~~~l~~e~~~~~~~~~~~~v~~l~~~ave~---E~~~~~~~~~-~~G-~~~~~~~yi~y~an  265 (324)
T PRK09614        196 RDESLHGYYIGYLFQEGLEELPELEQEELKDEIYDLLYELYEN---EEAYTELLYD-IVG-LAEDVKKYIRYNAN  265 (324)
T ss_pred             hhhHHHHHHHHHHHHHHHHhCCHhhhHHHHHHHHHHHHHHHHH---HHHHHHHHHC-cCC-CHHHHHHHHHHHHH
Confidence            5667888888888888887666666666788888888888866   4455666665 999 99999999999877


No 28 
>cd05173 PI3Kc_IA_beta Phosphoinositide 3-kinase (PI3K), class IA, beta isoform, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases. PI3Ks catalyze the transfer of the gamma-phosphoryl group from ATP to the 3-hydroxyl of the inositol ring of D-myo-phosphatidylinositol (PtdIns) or its derivatives. PI3Ks can be divided into three main classes (I, II, and III), defined by their substrate specificity, regulation, and domain structure. Class I PI3Ks are the only enzymes capable of converting PtdIns(4,5)P2 to the critical second messenger PtdIns(3,4,5)P3. Class I enzymes are heterodimers and exist in multiple isoforms consisting of one catalytic subunit (out of four isoforms) and one of several regulatory subunits. They are further classified into class IA (alpha, beta and de
Probab=32.41  E-value=84  Score=30.01  Aligned_cols=70  Identities=14%  Similarity=0.235  Sum_probs=55.3

Q ss_pred             hhHHHHHHHHHHHHHHhcCCCccHHHHH-----HhCCCCCH-HhHHHHHHHHhcCCChHHHHHHHHHHHhccCCCc
Q 026073          132 VISADLVGLCREIFIYMCDRDPAPRQVL-----LSLPCITP-QDLLAFEDALTKTASPREQKQHMRSLLVSGTGNN  201 (244)
Q Consensus       132 d~q~eL~~L~~~Iy~~l~p~~~~pr~vL-----~sLP~I~~-~~l~~f~~~L~~~~s~K~QR~l~~~LL~~~~g~~  201 (244)
                      +.....-.+|...|..+|......-.++     ..+|+++. +++..+.+.|.=..++++....|++++..+...+
T Consensus       272 ~~~~~F~~~c~~a~~~LRk~~~lil~l~~lM~~s~ip~~~~~~~i~~l~~r~~l~~se~eA~~~f~~~i~~s~~~~  347 (362)
T cd05173         272 EKFGRFRQYCEDAYLILRKNGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFRQKFDEALRES  347 (362)
T ss_pred             cchhHHHHHHHHHHHHHHhhHHHHHHHHHHHhcCCCccccchhHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhc
Confidence            3566788899999999997666544433     35888875 5899999999888899999999999999876554


No 29 
>PRK09169 hypothetical protein; Validated
Probab=29.13  E-value=3.1e+02  Score=32.57  Aligned_cols=123  Identities=15%  Similarity=0.176  Sum_probs=82.1

Q ss_pred             hhHHHHHhcCcccH----HHHHHHHhhhhc-cccCcchhhhhhhhhHHHHHHhccCchhHHHHHHHHHHHHHHHHh-ccc
Q 026073           55 KSMVGFLLKHKDLA----LPALQISLEAFT-WTDGEAVTKVSSFCSAVVLLAIQSNNIELQQFVSKDLFSAIIRGL-ALE  128 (244)
Q Consensus        55 ~~L~~~iL~~~~i~----~plL~~~~~~l~-wkDt~~~~~~~sf~~~lv~~~i~~~~~~l~efi~~ev~~a~L~~L-~~~  128 (244)
                      ..|.+.+..++...    .-=+..+.++|+ |.|...|..++.-....     +..++.++.-+-..=+.++|++| ..+
T Consensus       228 ~~lA~rL~~~~~l~~~l~~q~va~~LNAlSKWp~~~~c~~aa~~lA~r-----la~~~~lr~~~~~Q~vAN~LNALSKwp  302 (2316)
T PRK09169        228 ERLAERLADEPGLLQSLRAQEVALLLNALSKWPDDEACRQAAEALAAR-----LAREPGLRLALDPQGVANALNALSKWP  302 (2316)
T ss_pred             HHHHHHHhcChHHHHhcCHHHHHHHHHHHhcCCCChHHHHHHHHHHHH-----HhcChhhhhhcCHHHHHHHHHHHHhCC
Confidence            35667777666654    334567778887 99999999987543332     22566777777888888999999 444


Q ss_pred             chHhhHHHHHHHHHHHHHHhcCCCccHHHHHHhCCCCCHHhHHHHHHHHhcCCChHHHHHHHHHH
Q 026073          129 SNAVISADLVGLCREIFIYMCDRDPAPRQVLLSLPCITPQDLLAFEDALTKTASPREQKQHMRSL  193 (244)
Q Consensus       129 ~f~d~q~eL~~L~~~Iy~~l~p~~~~pr~vL~sLP~I~~~~l~~f~~~L~~~~s~K~QR~l~~~L  193 (244)
                      ....|..-...|...+....+         |  +..+++|+|.+.-..|.|=......|..+.-|
T Consensus       303 ~~~~cr~aa~~LA~rL~~~~~---------l--~~~~~aQ~vAN~LNALSKWp~~~~c~~Aa~~L  356 (2316)
T PRK09169        303 DTEACRQAAEALAERLAQERG---------L--LQAMNAQAVANALNALSKWPDEEACRAAAEAL  356 (2316)
T ss_pred             CchHHHHHHHHHHHHHHhChh---------h--hhhCCHHHHHHHHHHHhcCCCcHHHHHHHHHH
Confidence            444566666667776654322         1  56799999999999999844434444334333


No 30 
>cd00056 ENDO3c endonuclease III; includes endonuclease III (DNA-(apurinic or apyrimidinic site) lyase), alkylbase DNA glycosidases (Alka-family) and other DNA glycosidases
Probab=28.69  E-value=2.8e+02  Score=22.17  Aligned_cols=61  Identities=23%  Similarity=0.206  Sum_probs=38.8

Q ss_pred             HHHHHHHHHhcccchHhhHHHHHHHHHHHHHHhcCC---CccHHHHHHhCCCCCHHhHHHHHHHHhc
Q 026073          116 DLFSAIIRGLALESNAVISADLVGLCREIFIYMCDR---DPAPRQVLLSLPCITPQDLLAFEDALTK  179 (244)
Q Consensus       116 ev~~a~L~~L~~~~f~d~q~eL~~L~~~Iy~~l~p~---~~~pr~vL~sLP~I~~~~l~~f~~~L~~  179 (244)
                      +-+..|+.++.  |. .--.-+..+++.+...+...   ++..++-|++||||-+...+-+--.-..
T Consensus        42 ~~l~~~~~~~G--~~-~kA~~i~~~a~~~~~~~~~~~~~~~~~~~~L~~l~GIG~~tA~~~l~~~~~  105 (158)
T cd00056          42 EELRELIRSLG--YR-RKAKYLKELARAIVEGFGGLVLDDPDAREELLALPGVGRKTANVVLLFALG  105 (158)
T ss_pred             HHHHHHHHhcC--hH-HHHHHHHHHHHHHHHHcCCccCCCcccHHHHHcCCCCCHHHHHHHHHHHCC
Confidence            45667777766  21 12223444444444444433   3889999999999999988777665544


No 31 
>PF13495 Phage_int_SAM_4:  Phage integrase, N-terminal SAM-like domain; PDB: 2A3V_A.
Probab=27.19  E-value=47  Score=23.58  Aligned_cols=61  Identities=11%  Similarity=0.146  Sum_probs=36.0

Q ss_pred             hHHHHHHHHHHHHHHhcCCCccHHHHHHhCCCCCHHhHHHHHHHHhcC-----CChHHHHHHHHHHHhccCCCch
Q 026073          133 ISADLVGLCREIFIYMCDRDPAPRQVLLSLPCITPQDLLAFEDALTKT-----ASPREQKQHMRSLLVSGTGNNL  202 (244)
Q Consensus       133 ~q~eL~~L~~~Iy~~l~p~~~~pr~vL~sLP~I~~~~l~~f~~~L~~~-----~s~K~QR~l~~~LL~~~~g~~l  202 (244)
                      ..+.-..-+.....++..+         .+..|+++++.+|-..|...     .+-++-...++.|..++.+.+.
T Consensus        18 Ti~~Y~~~l~~f~~~~~~~---------~~~~it~~~i~~y~~~l~~~~~~s~~T~~~~~~~l~~ff~~~~~~~~   83 (85)
T PF13495_consen   18 TIKNYRYHLKRFLRFLGNK---------PPDEITPEDIEQYLNYLQNERGLSPSTINQYLSALRSFFRWLLERGY   83 (85)
T ss_dssp             HHHHHHHHHHHHHTTSSS-----------GGG--HHHHHHHHHHHHTTT---HHHHHHHHHHHHHHHHCTSS---
T ss_pred             HHHHHHHHHHHHHHHcccC---------ccchhHHHHHHHHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHcCCC
Confidence            4444444555544444423         56689999999999999832     2255666777888888877653


No 32 
>COG0208 NrdF Ribonucleotide reductase, beta subunit [Nucleotide transport and metabolism]
Probab=26.89  E-value=2.2e+02  Score=27.03  Aligned_cols=72  Identities=8%  Similarity=0.047  Sum_probs=52.7

Q ss_pred             CchhHHHHHHHHHHHHHHHHhcccchHhhHHHHHHHHHHHHHHhcCCCccHHHHHHhCCCCCHHhHHHHHHHHhc
Q 026073          105 NNIELQQFVSKDLFSAIIRGLALESNAVISADLVGLCREIFIYMCDRDPAPRQVLLSLPCITPQDLLAFEDALTK  179 (244)
Q Consensus       105 ~~~~l~efi~~ev~~a~L~~L~~~~f~d~q~eL~~L~~~Iy~~l~p~~~~pr~vL~sLP~I~~~~l~~f~~~L~~  179 (244)
                      .|..++-+....+++.....+-+....+++.+...++..+|..   .......++..+.|++.+.+.+|-+.+++
T Consensus       219 RDE~~H~~~~~~l~~~~~~e~~~~~t~e~~~~~~~l~~~ave~---E~~y~~~~~~~~~Glt~d~~~~Yi~y~an  290 (348)
T COG0208         219 RDEALHLYFIGYLIQRLVAENPELWTAELKDEIYDLFKEAVEL---EKEYAEYLYPGILGLTEDLVKQYIRYNAN  290 (348)
T ss_pred             HHHHHHHHHHHHHHHHHHHhCcHhhhHHHHHHHHHHHHHHHHH---HHHHHHHHhcccCCCCHHHHHHHHHHHHH
Confidence            4555666777778887777776766666777777777777755   33444445544899999999999999987


No 33 
>cd05175 PI3Kc_IA_alpha Phosphoinositide 3-kinase (PI3K), class IA, alpha isoform, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases. PI3Ks catalyze the transfer of the gamma-phosphoryl group from ATP to the 3-hydroxyl of the inositol ring of D-myo-phosphatidylinositol (PtdIns) or its derivatives. PI3Ks can be divided into three main classes (I, II, and III), defined by their substrate specificity, regulation, and domain structure. Class I PI3Ks are the only enzymes capable of converting PtdIns(4,5)P2 to the critical second messenger PtdIns(3,4,5)P3. Class I enzymes are heterodimers and exist in multiple isoforms consisting of one catalytic subunit (out of four isoforms) and one of several regulatory subunits. They are further classified into class IA (alpha, beta and 
Probab=26.72  E-value=1.6e+02  Score=28.32  Aligned_cols=71  Identities=8%  Similarity=0.173  Sum_probs=54.3

Q ss_pred             HhhHHHHHHHHHHHHHHhcCCCccHHH---HHH--hCCCCCH-HhHHHHHHHHhcCCChHHHHHHHHHHHhccCCCc
Q 026073          131 AVISADLVGLCREIFIYMCDRDPAPRQ---VLL--SLPCITP-QDLLAFEDALTKTASPREQKQHMRSLLVSGTGNN  201 (244)
Q Consensus       131 ~d~q~eL~~L~~~Iy~~l~p~~~~pr~---vL~--sLP~I~~-~~l~~f~~~L~~~~s~K~QR~l~~~LL~~~~g~~  201 (244)
                      .+.......+|...|..+|....-.-.   .|.  .+|+++. +++..+.+.+.=..++.+....|.+++....+.+
T Consensus       276 s~~f~~F~~lc~~ay~~lRk~~~~ii~L~~lM~~sgiP~l~~~~~i~~lr~rf~l~~sd~eA~~~f~~~I~~s~~~~  352 (366)
T cd05175         276 TREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGG  352 (366)
T ss_pred             CHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCcccCCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHhcC
Confidence            345567888999999999977654433   232  5888875 5899999999887899999999999998765443


No 34 
>PRK07209 ribonucleotide-diphosphate reductase subunit beta; Validated
Probab=26.03  E-value=2.1e+02  Score=27.12  Aligned_cols=72  Identities=11%  Similarity=0.050  Sum_probs=44.4

Q ss_pred             CchhHHHHHHHHHHHHHHHHhcccchHhhHHHHHHHHHHHHHHhcCCCccHHHHH-HhCCCCCHHhHHHHHHHHhc
Q 026073          105 NNIELQQFVSKDLFSAIIRGLALESNAVISADLVGLCREIFIYMCDRDPAPRQVL-LSLPCITPQDLLAFEDALTK  179 (244)
Q Consensus       105 ~~~~l~efi~~ev~~a~L~~L~~~~f~d~q~eL~~L~~~Iy~~l~p~~~~pr~vL-~sLP~I~~~~l~~f~~~L~~  179 (244)
                      .|..++-.++..++..++.-..+....+.+.++..++.+.+..=   ......++ .++.||+.+++.+|.+.+++
T Consensus       246 RDE~~H~~f~~~l~~~l~~e~p~~~~~~~~~~v~~l~~eav~~E---~~~~~~~~~~~i~Gl~~~~~~~Yi~y~An  318 (369)
T PRK07209        246 RDESMHLNFGIDLINQIKLENPHLWTAEFQAEIRELIKEAVELE---YRYARDTMPRGVLGLNASMFKDYLRFIAN  318 (369)
T ss_pred             HHHHHHHHHHHHHHHHHHHhCcccccHHHHHHHHHHHHHHHHHH---HHHHHHHcCCCCCCcCHHHHHHHHHHHHH
Confidence            34555555555666665543333333446777777777766541   12222222 25899999999999999886


No 35 
>PF04255 DUF433:  Protein of unknown function (DUF433);  InterPro: IPR007367 This is a family of uncharacterised proteins.; PDB: 2GA1_B.
Probab=25.45  E-value=1.5e+02  Score=20.22  Aligned_cols=31  Identities=19%  Similarity=0.343  Sum_probs=21.0

Q ss_pred             HHHHHhcCCCccHHHHHHhCCCCCHHhHHHHH
Q 026073          143 EIFIYMCDRDPAPRQVLLSLPCITPQDLLAFE  174 (244)
Q Consensus       143 ~Iy~~l~p~~~~pr~vL~sLP~I~~~~l~~f~  174 (244)
                      .|+..+ ....++.+|+...|+++.+++.+--
T Consensus        23 ~i~~~~-~~G~s~eeI~~~yp~Lt~~~i~aAl   53 (56)
T PF04255_consen   23 DILDLL-AAGESPEEIAEDYPSLTLEDIRAAL   53 (56)
T ss_dssp             HHHHHH-HTT--HHHHHHHSTT--HHHHHHHH
T ss_pred             HHHHHH-HcCCCHHHHHHHCCCCCHHHHHHHH
Confidence            455555 5788999999999999999987653


No 36 
>TIGR01083 nth endonuclease III. This equivalog model identifes nth members of the pfam00730 superfamily (HhH-GPD: Helix-hairpin-helix and Gly/Pro rich loop followed by a conserved aspartate). The major members of the superfamily are nth and mutY.
Probab=24.65  E-value=3.6e+02  Score=22.77  Aligned_cols=61  Identities=16%  Similarity=0.278  Sum_probs=37.9

Q ss_pred             HHHHHHHHHHhcccchHhhHHHHHHHHHHHHHHhcCCCccHHHHHHhCCCCCHHhHHHHHHHH
Q 026073          115 KDLFSAIIRGLALESNAVISADLVGLCREIFIYMCDRDPAPRQVLLSLPCITPQDLLAFEDAL  177 (244)
Q Consensus       115 ~ev~~a~L~~L~~~~f~d~q~eL~~L~~~Iy~~l~p~~~~pr~vL~sLP~I~~~~l~~f~~~L  177 (244)
                      .+-+..+|+++.-.  .---.-+..++..|...+....+..++-|++||||-+...+-+--.-
T Consensus        66 ~~~L~~~ir~~G~~--~~Ka~~i~~~a~~i~~~~~~~~~~~~~~L~~l~GIG~ktA~~ill~~  126 (191)
T TIGR01083        66 LEELEEYIKSIGLY--RNKAKNIIALCRILVERYGGEVPEDREELVKLPGVGRKTANVVLNVA  126 (191)
T ss_pred             HHHHHHHHHhcCCh--HHHHHHHHHHHHHHHHHcCCCCchHHHHHHhCCCCcHHHHHHHHHHH
Confidence            34455666665322  11122344444445555666667889999999999999877776444


No 37 
>PF06479 Ribonuc_2-5A:  Ribonuclease 2-5A;  InterPro: IPR010513 The proteins listed below share a common architecture with a protein kinase homology domain (see PDOC00100 from PROSITEDOC) followed by an ~135-residue globular kinase-extension nuclease (KEN) domain made of eight helices []:    - Mammalian 2-5A-dependent RNase or RNase L (EC 3.1.26.-), an interferon- induced enzyme implicated in both the molecular mechanisms of interferon action and the fundamental control of RNA stability. 2-5A-dependent RNase is a unique enzyme in that it requires 2-5A, unusual oligoadenylates with 2',5'-phosphodiester linkages. RNase L is catalytically active only after binding to an unusual activator molecule containing a 5'-phosphorylated 2', 5'-linked oligoadenylate (2-5A), in the N-terminal half. RNase L consists of three domains, namely the N-terminal ankyrin repeat domain (see PDOC50088 from PROSITEDOC), the protein kinase homology domain, and the C-terminal KEN domain [, , ].   - Eukaryotic Ire1/Ern1, an ancient transmembrane sensor of endoplasmic reticulum (ER) stress with dual protein kinase and ribonuclease activities. In response to ER stress Ire1/Ern1 catalyzes the splicing of target mRNAs in a spliceosome-independent manner. Ire1/Ern1 is a type 1 transmembrane receptor consisting of an N-terminal ER luminal domain, a transmembrane segment and a cytoplasmic region. The cytoplasmic region encompasses a protein kinase domain followed by a C-terminal KEN domain [, ].   The dimerisation of the kinase domain activates the ribonuclease function of the KEN domain [].; GO: 0016891 endoribonuclease activity, producing 5'-phosphomonoesters, 0006397 mRNA processing; PDB: 3SDJ_D 3FBV_L 3LJ2_A 3SDM_A 3LJ0_A 2RIO_A 3LJ1_A 3P23_A.
Probab=23.92  E-value=60  Score=26.36  Aligned_cols=37  Identities=19%  Similarity=0.113  Sum_probs=28.8

Q ss_pred             ccchHhhHHHHHHHHHHHHHHhcCCCccHHHHHHhCC
Q 026073          127 LESNAVISADLVGLCREIFIYMCDRDPAPRQVLLSLP  163 (244)
Q Consensus       127 ~~~f~d~q~eL~~L~~~Iy~~l~p~~~~pr~vL~sLP  163 (244)
                      ..|+-+.-.||+.+||....+|....+..+++|.++|
T Consensus        56 R~Y~~~sv~DLLR~IRNk~~Hy~el~~~~k~~lg~~p   92 (129)
T PF06479_consen   56 RKYDGDSVRDLLRAIRNKKHHYQELPEEVKEILGSLP   92 (129)
T ss_dssp             SS--TT-HHHHHHHHHHHHHTCCCS-HHHHHHC-STT
T ss_pred             cCCCccCHHHHHHHHHcchHhHHHCCHHHHHHhCCCc
Confidence            4488889999999999999999999888888887777


No 38 
>PF05918 API5:  Apoptosis inhibitory protein 5 (API5);  InterPro: IPR008383 This family consists of apoptosis inhibitory protein 5 (API5) sequences from several organisms. Apoptosis or programmed cell death is a physiological form of cell death that occurs in embryonic development and organ formation. It is characterised by biochemical and morphological changes such as DNA fragmentation and cell volume shrinkage. API5 is an anti apoptosis gene located in Homo sapiens chromosome 11, whose expression prevents the programmed cell death that occurs upon the deprivation of growth factors [,].; PDB: 3U0R_A 3V6A_A.
Probab=22.29  E-value=63  Score=32.65  Aligned_cols=21  Identities=33%  Similarity=0.395  Sum_probs=13.5

Q ss_pred             hHHHHHHHHHHHHHHHHhcCC
Q 026073            4 KLLRDLTREICSLLSTMASSG   24 (244)
Q Consensus         4 ~lLRqLTr~vv~ll~~~~~p~   24 (244)
                      ++|.++|.+=-.|+.+++..-
T Consensus       185 kvL~DVTaeEF~l~m~lL~~l  205 (556)
T PF05918_consen  185 KVLQDVTAEEFELFMSLLKSL  205 (556)
T ss_dssp             HHCTT--HHHHHHHHHHHHTS
T ss_pred             HHHHhccHHHHHHHHHHHHhC
Confidence            456777777777777777754


No 39 
>PF01736 Polyoma_agno:  Polyomavirus agnoprotein;  InterPro: IPR002643 This family consists of the DNA-binding protein or agnoprotein from various polyomaviruses. This protein is highly basic and can bind single stranded and double stranded DNA []. Mutations in the agnoprotein produce smaller viral plaques, hence its function is not essential for growth in tissue culture cells but something has slowed in the normal replication cycle []. There is also evidence suggesting that the agnogene and agnoprotein act as regulators of structural protein synthesis [].; GO: 0003677 DNA binding
Probab=22.28  E-value=85  Score=22.14  Aligned_cols=16  Identities=13%  Similarity=0.094  Sum_probs=11.6

Q ss_pred             HHHHhcCcccHHHHHHHHhh
Q 026073           58 VGFLLKHKDLALPALQISLE   77 (244)
Q Consensus        58 ~~~iL~~~~i~~plL~~~~~   77 (244)
                      |-|||    |++-+|.||..
T Consensus        27 RifiF----iLElLL~FC~G   42 (62)
T PF01736_consen   27 RIFIF----ILELLLEFCRG   42 (62)
T ss_pred             HHHHH----HHHHHHHHhcC
Confidence            77777    77777777753


No 40 
>KOG2122 consensus Beta-catenin-binding protein APC, contains ARM repeats [Signal transduction mechanisms; Cytoskeleton]
Probab=21.78  E-value=1.2e+03  Score=27.44  Aligned_cols=118  Identities=19%  Similarity=0.192  Sum_probs=76.6

Q ss_pred             hhhhccccCcchhhhhh---hhhHHHHHHhccCchhHHHHHHHHHHHHHHHHhcc---cchHhhHHHHHHHHHHHHHHhc
Q 026073           76 LEAFTWTDGEAVTKVSS---FCSAVVLLAIQSNNIELQQFVSKDLFSAIIRGLAL---ESNAVISADLVGLCREIFIYMC  149 (244)
Q Consensus        76 ~~~l~wkDt~~~~~~~s---f~~~lv~~~i~~~~~~l~efi~~ev~~a~L~~L~~---~~f~d~q~eL~~L~~~Iy~~l~  149 (244)
                      +.=|+|.|--+=..-|+   |...+| .++....++|.     .|..++|+-|.+   ........|+.++-+..-+.++
T Consensus       375 LTNLTFGDv~NKa~LCs~rgfMeavV-AQL~s~peeL~-----QV~AsvLRNLSWRAD~nmKkvLrE~GsVtaLa~~al~  448 (2195)
T KOG2122|consen  375 LTNLTFGDVANKATLCSQRGFMEAVV-AQLISAPEELL-----QVYASVLRNLSWRADSNMKKVLRETGSVTALAACALR  448 (2195)
T ss_pred             hhccccccccchhhhhhhhhHHHHHH-HHHhcChHHHH-----HHHHHHHHhccccccccHHHHHHhhhhHHHHHHHHHH
Confidence            33456777553333343   222222 22222233543     566778887733   3333355677788888888888


Q ss_pred             CCC-ccHHHHHHhCCCCCHH---------hHHHHHHHHhcCCChHHHHHHHHHHHhccCCC
Q 026073          150 DRD-PAPRQVLLSLPCITPQ---------DLLAFEDALTKTASPREQKQHMRSLLVSGTGN  200 (244)
Q Consensus       150 p~~-~~pr~vL~sLP~I~~~---------~l~~f~~~L~~~~s~K~QR~l~~~LL~~~~g~  200 (244)
                      -+. .+...||-.|=|+..+         ++|..-..|...-+++.|-. ++++|+.++|.
T Consensus       449 ~~kEsTLKavLSALWNLSAHcteNKA~iCaVDGALaFLVg~LSY~~qs~-tLaIIEsaGGI  508 (2195)
T KOG2122|consen  449 NKKESTLKAVLSALWNLSAHCTENKAEICAVDGALAFLVGTLSYEGQSN-TLAIIESAGGI  508 (2195)
T ss_pred             hcccchHHHHHHHHhhhhhcccccchhhhcccchHHHHHhhccccCCcc-hhhhhhcCccH
Confidence            777 8899999888877665         66777888888888887765 78888888774


No 41 
>PRK12759 bifunctional gluaredoxin/ribonucleoside-diphosphate reductase subunit beta; Provisional
Probab=21.01  E-value=2.8e+02  Score=26.65  Aligned_cols=72  Identities=6%  Similarity=0.050  Sum_probs=45.8

Q ss_pred             CchhHHHHHHHHHHHHHHHHhcccchHhhHHHHHHHHHHHHHHhcCCCccHHHHHH--hCCCCCHHhHHHHHHHHhc
Q 026073          105 NNIELQQFVSKDLFSAIIRGLALESNAVISADLVGLCREIFIYMCDRDPAPRQVLL--SLPCITPQDLLAFEDALTK  179 (244)
Q Consensus       105 ~~~~l~efi~~ev~~a~L~~L~~~~f~d~q~eL~~L~~~Iy~~l~p~~~~pr~vL~--sLP~I~~~~l~~f~~~L~~  179 (244)
                      .|..++-.++..+++....-..+....+.+.++..++.+.+..   .....+.++.  .+.||+.+++.+|.+.+++
T Consensus       280 RDE~lH~~~~~~l~~~l~~e~p~~~~~~~~~~v~~~~~eave~---E~~~~~~~~~~~~i~Gl~~~~~~~Yiky~an  353 (410)
T PRK12759        280 RDESMHVEGNAALFRIYCQENPYIVDNEFKKEIYLMASKAVEL---EDRFIELAYELGTIEGLKADEVKQYIRHITD  353 (410)
T ss_pred             HHHHHHHHHHHHHHHHHHHhChhhcChHHHHHHHHHHHHHHHH---HHHHHHHHcCCCCcCCCCHHHHHHHHHHHHH
Confidence            4555665666666666554333333344667777777777655   3333343443  4889999999999999877


No 42 
>KOG2583 consensus Ubiquinol cytochrome c reductase, subunit QCR2 [Energy production and conversion]
Probab=20.74  E-value=1.9e+02  Score=28.26  Aligned_cols=26  Identities=12%  Similarity=0.221  Sum_probs=23.5

Q ss_pred             cHHHHHHhCCCCCHHhHHHHHHHHhc
Q 026073          154 APRQVLLSLPCITPQDLLAFEDALTK  179 (244)
Q Consensus       154 ~pr~vL~sLP~I~~~~l~~f~~~L~~  179 (244)
                      +|..++.+|++|++.|+++.-.++..
T Consensus       384 ~~d~~i~~id~Vt~sdV~~a~kk~~s  409 (429)
T KOG2583|consen  384 EPDAFIQQIDKVTASDVQKAAKKFLS  409 (429)
T ss_pred             ChHHHHHHhccccHHHHHHHHHHhcc
Confidence            89999999999999999988887763


No 43 
>PRK14707 hypothetical protein; Provisional
Probab=20.72  E-value=5.6e+02  Score=30.70  Aligned_cols=124  Identities=18%  Similarity=0.191  Sum_probs=85.7

Q ss_pred             HHHHhhhhc-cccCcchhhhhh-hhhHHHHHHhccCchhHHHHHHHHHHHHHHHHh-cccchHhhHHHHHHHHHHHHHHh
Q 026073           72 LQISLEAFT-WTDGEAVTKVSS-FCSAVVLLAIQSNNIELQQFVSKDLFSAIIRGL-ALESNAVISADLVGLCREIFIYM  148 (244)
Q Consensus        72 L~~~~~~l~-wkDt~~~~~~~s-f~~~lv~~~i~~~~~~l~efi~~ev~~a~L~~L-~~~~f~d~q~eL~~L~~~Iy~~l  148 (244)
                      +.-.+++|+ |.|.+-|.-+.. ....|      ..+++++.-+-..-...+|++| ..|-..+|-....+|+..+-.--
T Consensus       291 vanalNalSKwpd~~vc~~Aa~~la~rl------~~d~~l~~~~~~~~~~~~LNalsKWpd~~~C~~Aa~~LA~rl~~d~  364 (2710)
T PRK14707        291 VTQALNALSKWADLPVCAEAAIALAERL------ADDPELCKALNARGLSTALNALSKWPDNPVCAAAVSALAERLVADP  364 (2710)
T ss_pred             HHHHHhhhhcCCCchHHHHHHHHHHHHH------hccHhhhhccchHHHHHHHHHhhcCCCchhHHHHHHHHHHHhccCH
Confidence            445667776 999998887773 33332      2577788877888889999999 67878889998888887654221


Q ss_pred             cCCCccHHHHHHhCCCCCHHhHHHHHHHHhcCCChHHHHHHHHHHHhccCCCc--hHHHhhhcccc
Q 026073          149 CDRDPAPRQVLLSLPCITPQDLLAFEDALTKTASPREQKQHMRSLLVSGTGNN--LKALAAQKSVN  212 (244)
Q Consensus       149 ~p~~~~pr~vL~sLP~I~~~~l~~f~~~L~~~~s~K~QR~l~~~LL~~~~g~~--l~a~~~~k~~~  212 (244)
                                 ....+++.+.+...-+.|.|=.-.-..|...+-|-..+.+..  .+++..|.=.|
T Consensus       365 -----------~l~~~l~~q~~a~~lNalsKWp~~~~c~~aa~~LA~~l~~d~~l~~~~~~Q~van  419 (2710)
T PRK14707        365 -----------ELRKDLEPQGVSSVLNALSKWPDTPVCAAAASALAEHVVDDLELRKGLDPQGVSN  419 (2710)
T ss_pred             -----------hhhcccchhHHHHHHhhhhcCCCchHHHHHHHHHHHHhccChhhhhhcchhhHHH
Confidence                       145577789999999999885555667777777766664432  33444444333


No 44 
>COG0177 Nth Predicted EndoIII-related endonuclease [DNA replication, recombination, and repair]
Probab=20.67  E-value=1.7e+02  Score=25.94  Aligned_cols=53  Identities=21%  Similarity=0.353  Sum_probs=38.7

Q ss_pred             HHHHHHHHHHHhcccchHhhHHHHHHHHHHHHHHhcCCCccHHHHHHhCCCCCHH
Q 026073          114 SKDLFSAIIRGLALESNAVISADLVGLCREIFIYMCDRDPAPRQVLLSLPCITPQ  168 (244)
Q Consensus       114 ~~ev~~a~L~~L~~~~f~d~q~eL~~L~~~Iy~~l~p~~~~pr~vL~sLP~I~~~  168 (244)
                      ..+-+...|+....  +-.=-+-+..+++.|.+.|...-|.-++-|++||||-+.
T Consensus        68 ~~~~l~~~I~~iGl--yr~KAk~I~~~~~~l~e~~~g~vP~~~~eL~~LPGVGrK  120 (211)
T COG0177          68 DEEELEELIKSIGL--YRNKAKNIKELARILLEKFGGEVPDTREELLSLPGVGRK  120 (211)
T ss_pred             CHHHHHHHHHhcCC--cHHHHHHHHHHHHHHHHHcCCCCCchHHHHHhCCCcchH
Confidence            34455566653322  222345688889999999999999999999999999776


No 45 
>PF00633 HHH:  Helix-hairpin-helix motif;  InterPro: IPR000445 The HhH motif is an around 20 amino acids domain present in prokaryotic and eukaryotic non-sequence-specific DNA binding proteins [, , ]. The HhH motif is similar to, but distinct from, the HtH motif. Both of these motifs have two helices connected by a short turn. In the HtH motif the second helix binds to DNA with the helix in the major groove. This allows the contact between specific base and residues throughout the protein. In the HhH motif the second helix does not protrude from the surface of the protein and therefore cannot lie in the major groove of the DNA. Crystallographic studies suggest that the interaction of the HhH domain with DNA is mediated by amino acids located in the strongly conserved loop (L-P-G-V) and at the N-terminal end of the second helix []. This interaction could involve the formation of hydrogen bonds between protein backbone nitrogens and DNA phosphate groups []. The structural difference between the HtH and HhH domains is reflected at the functional level: whereas the HtH domain, found primarily in gene regulatory proteins, binds DNA in a sequence specific manner, the HhH domain is rather found in proteins involved in enzymatic activities and binds DNA with no sequence specificity []. The HhH domain of DisA, a bacterial checkpoint control protein, is a DNA-binding domain [].; GO: 0003677 DNA binding; PDB: 3C1Z_A 3C23_A 3C1Y_A 3C21_A 1Z00_A 2A1J_B 1KEA_A 1VRL_A 1RRQ_A 3G0Q_A ....
Probab=20.27  E-value=1.4e+02  Score=18.01  Aligned_cols=21  Identities=38%  Similarity=0.564  Sum_probs=14.2

Q ss_pred             ccHHHHHHhCCCCCHHhHHHH
Q 026073          153 PAPRQVLLSLPCITPQDLLAF  173 (244)
Q Consensus       153 ~~pr~vL~sLP~I~~~~l~~f  173 (244)
                      +.-++=|++||||-++.-++.
T Consensus         7 pas~eeL~~lpGIG~~tA~~I   27 (30)
T PF00633_consen    7 PASIEELMKLPGIGPKTANAI   27 (30)
T ss_dssp             TSSHHHHHTSTT-SHHHHHHH
T ss_pred             CCCHHHHHhCCCcCHHHHHHH
Confidence            344667899999998865543


Done!